Method and system for classifying analyte data into clusters
A computer-based flow cytometry data classification method, utilizing regression models and clustering algorithms, addresses the issues of low accuracy and poor reproducibility in flow cytometry data classification, thereby improving the efficiency and accuracy of data cleaning.
Patent Information
- Application Number
- CN202410878433.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-09
- Filing Date
- 2024-07-02
- Publication Date
- 2024-11-12
AI Technical Summary
Existing flow cytometry data classification methods suffer from low accuracy and poor reproducibility, especially when removing fragmented and multivariate data, and the data cleaning process caused by manual gating is complex and inconsistent.
A computer-based approach was adopted to determine the relationship between the characteristics of the analytes and the clustering criteria through a regression model. Sparse sets were generated and classification models were applied to classify the analyte data into clusters. Algorithms such as Gaussian mixture model, DBSCAN, K-means clustering, BIRCH, and spectral clustering were used for data clustering.
It improves the accuracy and efficiency of data classification, reduces errors caused by manual gating, and achieves higher repeatability and consistency.
Smart Images

Figure CN118940059A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority under 35 USC §119(e) to the filing date of U.S. Provisional Patent Application Serial No. 63 / 465,057, filed on May 9, 2023, the disclosure of which is incorporated herein by reference in its entirety. Technical Field
[0003] The present application relates to methods and systems for classifying analyte data into clusters. Background Art
[0004] Characterization of analytes in biological fluids has become an important part of biological research, medical diagnostics, and assessment of the overall health and well-being of patients. Detection of analytes in biological fluids (e.g., human blood or blood-derived products) can provide results that play a role in determining treatment regimens for patients with a variety of disease conditions.
[0005] Flow cytometry is a technique for characterizing and often sorting particles of interest in biological materials such as cells of a blood sample or another type of biological or chemical sample. A flow cytometer typically includes a sample reservoir for receiving a fluid sample (e.g., a blood sample) and a sheath reservoir containing a sheath fluid. The flow cytometer delivers particles (including cells) in a fluid sample to a flow cell as a cell stream, while also directing the sheath fluid to the flow cell. In order to characterize the components of the flow stream, the flow stream is illuminated with light. Changes in the material in the flow stream (e.g., the presence of morphology or fluorescent markers) may cause changes in the observed light, and these changes allow for characterization and separation. In order to characterize the components in the flow stream, light must be incident on the flow stream and collected. The light source in a flow cytometer can vary and may include one or more broad spectrum lamps, light emitting diodes, and single wavelength lasers. The light source is aligned with the flow stream, and the optical response from the irradiated particles is collected and quantified.
[0006] Separation of biological particles has been achieved by adding sorting or collection capabilities to flow cytometers. Particles in the separation stream that are detected as having one or more desired characteristics are individually separated from the sample stream by mechanical or electrical removal. Common flow sorting techniques utilize droplet sorting, in which a flow stream containing linearly separated particles is divided into droplets. Droplets containing particles of interest are charged and deflected through an electric field into a collection tube. Typically, linearly separated particles in the stream are characterized when they pass through an observation point located just below the nozzle tip. Once a particle is identified as meeting one or more desired criteria, it is possible to predict the time when it will reach the droplet breakoff point and break off from the stream in the droplet. Ideally, a brief charge is applied to the fluid stream before the droplet containing the selected particle breaks off from the fluid stream, and then grounded immediately after the droplet breaks off. The droplet to be sorted retains the charge when it breaks off the fluid stream, and all other droplets remain uncharged.
[0007] Parameters measured using a flow cytometer typically include light of the excitation wavelength scattered by particles at narrow angles in a primarily forward direction, known as forward scatter (FSC), excitation light scattered by particles in a direction orthogonal to the excitation laser, known as side scatter (SSC), and light emitted by fluorescent molecules in one or more detectors that measure signals over a range of spectral wavelengths, or light emitted by fluorescent dyes that are detected primarily in a specific detector or detector array. Different cell types can be identified by their light scattering properties and by fluorescence emissions resulting from labeling various cellular proteins or other components with antibodies or other fluorescent probes labeled with fluorescent dyes.
[0008] The flow cytometer may further include components for recording measured data and analyzing data. For example, a computer connected to the detection electronics may be used for data storage and analysis. For example, the data may be stored in a tabular form, where each row corresponds to data for one particle, and the columns correspond to the features of each measurement. Using a standard file format (e.g., an "FCS" file format) to store data from a particle analyzer facilitates the use of separate programs and / or machines to analyze the data. Using current analysis methods, data is typically displayed in a one-dimensional histogram or a two-dimensional (2D) graph for ease of visualization, but other methods may also be used to visualize multidimensional data.
[0009] Although flow cytometry data typically contains a large number of data points (i.e., events), it is often the case that users are only interested in specific portions of the flow cytometry data. For example, it may be necessary to identify optimal parameters to discriminate debris / small particles from single cells and multiplets. Fragments are essentially cell fragments that have been broken up during processing. Multiplets are two or more cells that are connected together. Cell fragments can be considered "junk" or data that users do not want to collect or process for further analysis. Multiplets are also events that are desired to be removed from the analysis because the fluorescent signal obtained from these multiplets is twice that observed in single cells, i.e., they are outlier events. Removing such debris and multiplets is usually the first step in analyzing flow data. In other words, doublet and cluster exclusion are key preliminary steps in establishing pure sorting. Doublets can confuse purity and may lead to unnecessary results or unnecessary costs when performing downstream functional and or genomic analyses. Summary of the invention
[0010] The present disclosure provides improvements to the process of classifying analyte data (e.g., flow cytometer data), for example, in the process of removing data associated with unwanted analytes (e.g., fragments, multiplets, etc.). It has been found that artificial gating of singlets (SSC-A relative to FSC-A) can cause 40% of true non-singlet states to be incorrectly classified as singlets. In addition, analyte classifications often vary greatly between different users, thereby hindering the generalizability and reproducibility of the results. Therefore, a simplified process for data cleaning is needed. In particular, an automated process is needed to clean up the data to minimize the removal of events of interest that may be caused by drawing manual gates. Embodiments of the present disclosure meet these and other needs.
[0011] Aspects of the present disclosure include computer-implemented methods for classifying analyte data. The method of interest includes applying a regression model via a processor to determine the relationship between an initial set of analyte features and a clustering criterion, generating a sparse set based on the relationship from at most a portion of the initial set of analyte features, generating a classification model based on the sparse set, and applying the classification model to classify the analyte data into clusters. In some embodiments, the analyte data is flow cytometer data. In some such embodiments, the clustering criterion is the association of the analyte data with a singlet. In some cases, clustering includes singlet clustering and non-singlet clustering. In some versions, the analyte features include size features, imaging features, scattering features, or any combination thereof. In some cases, the classification model includes a mixed model, such as a Gaussian mixture model. In other cases, the classification model includes a density-based spatial clustering (DBSCAN) algorithm for applications with noise. In other cases, the classification model includes a balanced iterative reduction and clustering (BIRCH) algorithm using a hierarchy. In other cases, the classification model includes a K-means clustering algorithm. In other cases, the classification model includes a spectral clustering algorithm. In some cases, the initial set of analyte features includes 5 to 20 analyte features (e.g., 9 to 11 analyte features). In some versions, the sparse set of analyte features includes 2 to 10 analyte features (e.g., 2 to 4 analyte features). In some versions, classifying the analyte data includes including 90% or more (e.g., 97% or more) of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria. In some cases, classifying the analyte data includes excluding 85% or more (e.g., 92% or more) of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0012] Aspects of the present disclosure also include systems. The system of interest includes a memory operably coupled to a processor, wherein the memory includes instructions stored thereon, and the instructions, when executed by the processor, cause the processor to implement the method of the present disclosure (e.g., as described above and described herein). In other words, the processor is configured to apply a regression model to determine the relationship between the initial set of analyte features and the clustering criteria, generate a sparse set based on the relationship from at most a portion of the initial set of analyte features, generate a classification model based on the sparse set, and apply the classification model to classify analyte data into clusters. In some instances, the system is or includes (e.g., operably connected to) a flow cytometer. In some versions, the flow cytometer is an imaging-enabled flow cytometer. The method of the present disclosure may in some cases be related to providing analyte data to the system of the present disclosure, and receiving classified analyte data from the system.
[0013] Aspects of the present disclosure also include a non-transitory computer-readable storage medium including instructions stored thereon for classifying analyte data by the method of the present disclosure. In other words, the instructions are for classifying the analyte data by applying a regression model to determine a relationship between an initial set of analyte features and a clustering criterion, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and applying the classification model to classify the analyte data into clusters. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] The present disclosure may be better understood from the following detailed description when read in conjunction with the accompanying drawings, which include the following figures:
[0015] Figure 1 A flow chart is shown for practicing a method of classifying analyte data, according to certain embodiments.
[0016] Figure 2 Shown is a flow cytometry system according to certain embodiments.
[0017] Figure 3 An image-enabled particle sorter is depicted, according to certain embodiments.
[0018] Figure 4 Depicted is a functional block diagram of a particle analysis system according to certain embodiments.
[0019] Figure 5 A functional block diagram of one example of a control system according to certain embodiments is depicted.
[0020] FIG. 6A to FIG. 6B Depicted is a schematic diagram of a particle sorter system according to certain embodiments.
[0021] Figure 7 Aspects of a computer controlled system according to certain embodiments are described.
[0022] FIG. 8A to FIG. 8B Describes the method used to implement feature selection ( Fig. 8A ) and Gaussian mixture modeling ( Figure 8B ) flow chart.
[0023] Fig. 9 The imaging features used in the manual gating method are depicted, as well as the distribution of lymphocytes, monocytes, and high-scatter events.
[0024] FIG. 10A to FIG. 10B Results from the non-singlet exclusion method imaged separately are depicted.
[0025] FIG. 11A to FIG. 11BResults from the height versus width plus imaging non-singlet exclusion method are depicted.
[0026] FIG. 12A to FIG. 12B Results from the height versus area plus imaging non-singlet exclusion method are depicted.
[0027] FIG. 13A to FIG. 13B The non-singlet exclusion in different methods was compared ( Fig.13A ) and singlet retention ( Fig. 13B ).
[0028] FIG. 14A to FIG. 14B The clustering results are shown.
[0029] Fig.15 Box-whisker plots of singlet inclusion and non-singlet exclusion are shown. DETAILED DESCRIPTION
[0030] A computer-implemented method for classifying analyte data is provided. The method of interest includes applying a regression model to determine a relationship between an initial set of analyte features and a clustering criterion, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and applying the classification model to classify the analyte data into the clusters. A system and a non-transitory computer-readable storage medium configured to implement the subject method are also provided.
[0031] Before describing the present disclosure in more detail, it should be understood that the present disclosure is not limited to the particular embodiments described, and therefore may of course vary. It should also be understood that the terminology used herein is only for the purpose of describing particular embodiments and is not intended to be limiting, as the scope of the present disclosure is limited only by the appended claims.
[0032] Where a numerical range is provided, it is understood that unless the context clearly dictates otherwise, each intervening value (to one tenth of the unit of the lower limit) between the upper and lower limits of the range, and any other specified or intermediate values within the stated range, are encompassed within the disclosure. The upper and lower limits of these smaller ranges may be independently included in the smaller ranges and are also encompassed within the disclosure, subject to any specifically excluded limits in the stated ranges. Where a stated range includes one or both limits, ranges excluding either or both of these included limits are also encompassed within the disclosure.
[0033] Certain ranges are given herein where a numerical value is preceded by the term "about". The term "about" is used herein to provide literal support for the exact number that follows it, as well as for numbers that are close to or approximately following the term. In determining whether a number is close to or approximately a specifically recited number, a close or approximate unrecited number may be a number that, in the context in which it appears, provides a substantial equivalent to the specifically recited number.
[0034] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, representative illustrative methods and materials are now described.
[0035] All publications and patents cited in this specification are incorporated herein by reference as if each individual publication or patent was specifically and individually indicated to be incorporated by reference and is incorporated herein by reference to disclose and describe the methods and / or materials related to the cited publication. The citation of any publication is due to its disclosure prior to the filing date and should not be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. In addition, the publication dates provided may be different from the actual publication dates, which may need to be independently confirmed.
[0036] It should be noted that as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. It should also be noted that the claims can be drafted to exclude any optional elements. As such, this statement is intended to serve as antecedent basis for use of such specific terminology as "solely," "only," etc. in connection with the recitation of claim elements, or for use of a "negative" limitation.
[0037] As will be apparent to those skilled in the art after reading this disclosure, each individual embodiment described and illustrated herein has discrete components and features that can be readily separated or combined with the features of any other several embodiments without departing from the scope or spirit of the present disclosure. Any recited method can be performed in the order of events recited or in any other order that is logically possible.
[0038] Although the system and method have been or will be described for the sake of grammatical fluency and functional interpretation, it should be clearly understood that unless expressly stated in accordance with 35 U.S.C. §112, the claims should not be interpreted as necessarily being limited in any way to the "components" or "steps" limitations, but should be consistent with the full scope of the meaning and equivalents provided by the claims in accordance with the judicial doctrine of equivalents, and in the event that the claims are expressly stated in accordance with 35 U.S.C. §112, they will be given full legal equivalents in accordance with 35 U.S.C. §112.
[0039] Methods for classifying analyte data
[0040] Aspects of the present disclosure include computer-implemented methods for classifying analyte data into clusters. "Analyte data" means data obtained by evaluating certain characteristics of a specific analyte. "Classification" of analyte data means that analyte data (such as a group of analyte data) is designated as belonging to a specific type in one or more possible different types to which the data may belong. The method of the present disclosure may be sufficient to improve analyte data classification relative to conventional classification methods in some cases, such as when analyte data is manually classified by a user (for example, by drawing a gate on flow cytometer data). For example, in certain embodiments, the subject method can improve classification accuracy. Accuracy can be determined by assessing whether each analyte or data point / event associated therewith does belong to its classified specific type. In some cases, the method of the present disclosure can improve classification accuracy by 1% or more, such as 5% or more, such as 10% or more, such as 15% or more and including 20% or more relative to conventional methods (such as drawing a manual gate). In embodiments, practice subject method is enough to improve the speed and / or efficiency of analyte data classification relative to conventional methods (e.g., drawing manual gates), for example, improve 1% or more, for example 5% or more, for example 10% or more, for example 15% or more and include 20% or more. As mentioned above, the method of the present disclosure is a computer-implemented method. In other words, the method steps described herein can be implemented via a processor associated with a computer system. Any suitable processor can be used in the subject method, such as those described below about the system of the present disclosure.
[0041] In some cases, analyte data is flow cytometer data. "Flow cytometer data" means information about the characteristics of sample particles collected by any number of detectors in a particle analyzer. As discussed herein, a "particle analyzer" is an analytical tool (e.g., a flow cytometer) that is capable of characterizing particles based on certain (e.g., optical) parameters. "Particle" means a discrete component of a biological sample, such as a molecule, a bead that binds an analyte, a separate cell, etc. Although the present disclosure is primarily described in terms of flow cytometer data, the applicability of the present disclosure is not limited to flow cytometer data. In some cases, the present disclosure may be applicable to other types of data, such as nucleic acid data.
[0042] Flow cytometer data can be received from any suitable source. In some embodiments, flow cytometer data is received from the memory of a storage device. In such embodiments, flow cytometer data may have been pre-generated and stored in the memory of a storage device for subsequent calls and analysis. In other embodiments, flow cytometer data is received in real time. In other words, the flow cytometer data generated during the operation of the flow cytometer can subsequently (e.g., immediately) fill the data space (e.g., two-dimensional graph). In embodiments, flow cytometer data is received from a forward scattering detector. In some instances, a forward scattering detector can generate information about the overall size of a particle. In embodiments, flow cytometer data is received from a side scattering detector. In some instances, a side scattering detector can be configured to detect refracted light and reflected light from the surface and internal structure of a particle, which often increases with the increase of the complexity of the particle structure.
[0043] In certain embodiments, as required, the particle is detected and uniquely identified by exposing the particle to the excitation light and measuring the fluorescence of each particle in one or more detection channels. The fluorescence emitted in the detection channel for identifying the particle and the binding complex associated therewith can be measured after being excited with a single light source, or can be measured separately after being excited with different light sources. If a separate excitation light source is used to excite the particle marker, the marker can be selected so that all markers can be excited by each excitation light source used. In an embodiment, flow cytometer data is received from a fluorescence detector. In some instances, the fluorescence detector can be configured to detect the fluorescence emission from the fluorescent molecule, such as the specific binding member of the label associated with the particle in the flow cell (such as an antibody specifically bound to the label of the marker of interest). In certain embodiments, the method includes detecting the fluorescence from the sample with one or more fluorescence detectors, such as 2 or more, such as 3 or more, such as 4 or more, such as 5 or more, such as 6 or more, such as 7 or more, such as 8 or more, such as 9 or more, such as 10 or more, such as 15 or more and including 25 or more fluorescence detectors. In embodiments, each fluorescence detector is configured to generate a fluorescence data signal. Fluorescence from a sample can be independently detected by each fluorescence detector within one or more wavelength ranges of 200nm-1200nm. In some instances, the method includes detecting fluorescence from a sample within a certain wavelength range, such as 200nm to 1200nm, such as 300nm to 1100nm, such as 400nm to 1000nm, such as 500nm to 900nm and including 600nm to 800nm. In other instances, the method includes detecting fluorescence at one or more specific wavelengths with each fluorescence detector. For example, fluorescence can be detected at one or more of 450nm, 518nm, 519nm, 561nm, 578nm, 605nm, 607nm, 625nm, 650nm, 660nm, 667nm, 670nm, 668nm, 695nm, 710nm, 723nm, 780nm, 785nm, 647nm, 617nm and any combination thereof, depending on the number of different fluorescence detectors in the subject light detection system. In certain embodiments, the method includes detecting the light wavelength corresponding to the fluorescence peak wavelength of some fluorophores present in the sample. In embodiments, flow cytometer data is received from one or more light detectors (e.g., one or more detection channels), such as 2 or more, such as 3 or more, such as 4 or more, such as 5 or more, such as 6 or more and including 8 or more light detectors (e.g., 8 or more detection channels).
[0044] In some cases, method can include multiple sets of analyte data are classified, such as 2 or more sets, 3 or more sets, 4 or more sets, 5 or more sets, 7 or more sets, 8 or more sets, 9 or more sets, and include 10 or more sets. In such cases, the set can be from the same source or different sources. The number of data points (such as events, observations) classified by the subject method can also change. In some cases, the number of data points is 1k to 100k, such as 10k to 80k, such as 20k to 60k and including 25k to 50k. In some embodiments, the number of data points is 1k or greater, for example 5k or greater, for example 10k or greater, for example 15k or greater, for example 20k or greater, for example 25k or greater, for example 30k or greater, for example 35k or greater, for example 40k or greater, for example 45k or greater, for example 50k or greater, for example 55k or greater, for example 60k or greater, for example 65k or greater, for example 70k or greater, for example 75k or greater, for example 80k or greater, for example 85k or greater, for example 90k or greater, for example 95k or greater and including 100k or greater.
[0045] In some cases, before clustering the analyte data, the method includes preprocessing the data, e.g., so that it is in a more suitable form for manipulation by different models. Any suitable preprocessing scheme can be used. In some embodiments, the method includes standardizing the analyte features, e.g., so that they are centered around the mean and scaled to unit variance.
[0046] The method disclosed herein includes applying a regression model to determine the relationship between the initial set of analyte features and the clustering criteria. "Analyte feature" means one or more properties (such as optical properties, impedance properties and / or time properties) associated with each individual analyte (such as particle), so that each analyte is present in the analyte data as a set of digital feature values. According to the requirements of a given experiment, the number of analyte features present in the data can vary, and can include, for example, 10 or more features, such as 20 or more features, such as 30 or more features, such as 40 or more features, such as 50 or more features, and include 60 or more features. In some instances, analyte features are selected from size features, imaging features and scattering features. In some such instances, analyte features are scattering features selected from side scatter (SSC) features and forward scatter (FSC) features. In the case where analyte data is flow cytometer data, analyte features can also be associated with and / or obtained from fluorescence, axial light loss (ALL) etc. Exemplary characteristics include, but are not limited to, size, center of mass, minor axis moment, diffusivity, major axis moment, radial moment, maximum intensity, and eccentricity. In embodiments, the analyte characteristic comprises an imaging characteristic.
[0047] " Clustering criteria " discussed herein can be any suitable criteria, and analyte data can be evaluated and classified into clusters relative to the criteria. For example, clustering criteria can be the association of analyte data with a certain parameter of interest. If the analyte corresponding to the data can be said to correspond to the parameter, i.e. it is therefore positive, then it can be considered that analyte data is "associated" with the parameter of interest. Such analyte data can be classified into specific clusters, and the analyte data not corresponding to the clustering criteria can be classified into one or more other clusters (e.g., clusters that are negative for the parameter of interest). In some embodiments, the analyte data not corresponding to the clustering criteria can be classified into a single cluster (i.e., so that there are a total of 2 clusters). Alternatively, the analyte data not corresponding to the clustering criteria can be classified into multiple clusters according to some other criteria, such as 2 or more clusters, 3 or more clusters, 4 or more clusters, 5 or more clusters, 6 or more clusters, 7 or more clusters, 8 or more clusters, 9 or more clusters, and include 10 or more clusters. The clustering criteria can vary according to the nature of the analyte being observed and / or the nature of the experiment being performed. In some cases, the clustering criteria is the association of the analyte data with the singlet. In such cases, the flow cytometer data associated with the singlet can be classified into the singlet cluster, and the flow cytometer not associated with the singlet can be classified into one or more non-singlet clusters. The non-singlet that can be classified into the non-singlet cluster can include but is not limited to multiplets / aggregates (e.g., doublets, triplets, quartets; quintets; etc.), fragments (e.g., components of dissolved cells), etc. According to the above, the non-singlet can be classified into a single non-singlet cluster, or can be further divided into multiple non-singlet clusters (e.g., one of the clusters corresponds to a doublet, one cluster corresponds to a fragment, and so on and so forth as appropriate). In some cases, the non-singlet cluster includes doublets or aggregates. Other clustering criteria can include the association with a specific fluorescent marker, which itself can be associated with a specific phenotype of the analyte according to the nature of the experiment being performed. In some embodiments, the clustering criterion is the size or shape of the analytes.
[0048] The "initial" set of analyte features is a subset of analyte features from the total of possible analyte features (e.g., analyte features that can be obtained from a given flow cytometer in an experiment with specific constraints), which have been found to have a relationship with the clustering criteria via a regression model, so that relative to other analyte features in the total of possible analyte features, the initial set is more useful for predicting the classification of analyte data to clusters according to the clustering criteria. In some cases, when considered as a whole, the analyte features in the initial set are more predictive than the total of possible analyte features by 1% or more, such as 5% or more, such as 10% or more, such as 15% or more, such as 20% or more, such as 25% or more, such as 30% or more, such as 35% or more, such as 40% or more, and include 50% or more. The regression model can be any model configured to estimate the relationship between analyte features and clustering criteria. In some cases, the regression model adopts linear regression. In other cases, the regression model adopts nonlinear regression. The regression model may in some instances involve, for example, Bayesian methods, percentage regression, scenario optimization, least absolute deviation, nonparametric regression, scenario optimization, distance metric learning, etc.
[0049] The number of analyte features in the initial set can vary. In some cases, the initial set of analyte features includes 5 to 20 analyte features, such as 7 to 15 analyte features, and includes 9 to 11 analyte features. In some cases, the initial set of analyte features includes 5 analyte features, 6 analyte features, 7 analyte features, 8 analyte features, 9 analyte features, 10 analyte features, 11 analyte features, 12 analyte features, 13 analyte features, 14 analyte features, 15 analyte features, 16 analyte features, 17 analyte features, 18 analyte features, 19 analyte features or 20 analyte features. The number of analyte features can also be described as the percentage of the number of analyte features in the totality of possible analyte features. In some cases, the initial set of analyte features includes 10% or more of the possible analyte features, such as 11% or more, 12% or more, 13% or more, 14% or more, 15% or more, 16% or more, 17% or more, 18% or more, 19% or more, 20% or more, 21% or more, 22% or more, 23% or more, 24% or more, and including 25% or more. In some embodiments, the initial set includes both imaging analyte features and non-imaging analyte features.
[0050] The method disclosed herein also includes generating a sparse set from at most a portion of the initial set of analyte features based on the relationship. "Sparse set" means a subset of the initial set of analyte features further refined based on the predictability relative to the clustering criteria. In other words, the sparse set optimizes the inclusion rate of the analyte data (e.g., singlet) associated with the clustering criteria from the clustering and the exclusion rate of the analyte data (e.g., non-singlet) not associated with the clustering criteria. The number of analyte features in the sparse set can vary in some instances, and can be, for example, 2 to 10 analyte features, such as 2 to 5 analyte features, and including 2 to 4 analyte features in the range. In some cases, the sparse set includes 2 analyte features, 3 analyte features, 4 analyte features, 5 analyte features, 6 analyte features, 7 analyte features, 8 analyte features, 9 analyte features or 10 analyte features. In some cases, the sparse set includes 10% or more of the analyte features from the initial set, such as 15% or more, such as 20% or more, such as 25% or more, such as 30% or more, such as 35% or more and including 40% or more.
[0051] In some cases, the scheme of generating sparse set can be changed.In some instances, generating sparse set of analyte feature includes iteratively adjusting the analyte feature of initial set.In embodiments, iterative adjustment relates to estimating experimental inclusion rate and exclusion rate relative to clustering standard.In other words, iterative adjustment relates to estimating the real inclusion rate of analyte data in clustering associated with clustering standard, and excluding analyte data not associated with clustering standard from the same cluster.In the specific example related to singlet and non-singlet, iterative adjustment relates to estimating the real singlet inclusion rate and real non-singlet exclusion rate of experiment.Adjustment can be iterated until finding optimal rate.In some cases, the generation of sparse set relates to iteratively testing the accuracy of different combinations of analyte feature (for example, about real singlet inclusion rate and real non-singlet exclusion rate), and the combination with the highest accuracy is considered to be optimal.In some embodiments, sparse set includes both imaging analyte feature and non-imaging analyte feature.
[0052] In an embodiment, a sparse set of analyte features can be generated based on training data. In some cases, training data is used during application of regression models, iterative adjustments, or both. Training data can be received from any suitable source. In some embodiments, training data is received from the memory of a storage device. In such embodiments, training data may have been previously generated and stored in the memory of a storage device for subsequent calls and analysis. In an embodiment, the analyte data in the training data set has a known classification. For example, in some cases where the training data set includes flow cytometer data, each individual analyte may have been confirmed to correspond to one category or another category by some other means. In some instances, an expert user manually provides classification for the training data set. This can include, for example, manually drawing a gate on a two-dimensional graph of flow cytometer data. For training purposes, analyte features from the training data set and these classifications can be provided. In other words, training data can be considered as "basic facts" data. In some versions, such basic facts data are obtained by adopting a specific stain or dye known to correspond to the analyte characteristics of interest in a flow cytometer experiment. The stain or dye can be selected according to the nature of the characteristic. For example, in the case of desired clustering singlet and non-singlet states, DNA intercalating dyes can be used to obtain basic fact data. Cells (at least cells of eukaryotic species) generally have a single nucleus containing DNA. The DNA is dyed to allow the user to reliably determine whether a given event / observation involves a cell (i.e., singlet) or multiple cells (i.e., non-singlet). Available DNA intercalating dyes include, but are not limited to, ethidium bromide, SYBR green, propidium iodide, acridine orange, DAPI, and DRAQ5. In some embodiments, the method includes training using multiple training data sets, such as 2 or more training data sets, such as 3 or more training data sets, such as 4 or more training data sets, and including 5 or more training data sets.
[0053] In addition to the above, the method includes generating a classification model based on a sparse set. Any classification model suitable for clustering analyte data can be adopted. In some cases, the classification model is a machine learning algorithm. In some versions, the classification model is or includes a mixed model. The mixed model represents a combination of probability distributions. Each distribution can be a different subgroup or cluster in the data. These component distributions can be different types, such as Gaussian distribution (normal distribution), exponential distribution or other distributions, depending on the nature of the data to be modeled. In a mixed model, it is assumed that each data point is generated by one of the component distributions, wherein the possibility generated by each component is determined by the parameters of the model. These parameters generally include the weight (or ratio) of each component and the parameters (such as mean (μ), covariance (∑)) of each component distribution. Details about the mixture model can be found in, for example, McNicholas, PD (2016). "Classification based on mixed models (Mixture model-basedclassification)"; it is incorporated herein by reference.
[0054] In certain embodiments, the mixture model comprises a Gaussian mixture model. In such embodiments, the method involves assuming that the analyte data comprises a Gaussian mixture (i.e., a Gaussian distribution). In one exemplary version, the method comprises initializing the mean μ c , covariance∑ c and the score of each cluster Π c , and the probability that each data point in the analyte data belongs to cluster c is calculated:
[0055]
[0056] where N(x|μ,∑) describes a multivariate Gaussian, where:
[0057]
[0058] For each cluster c, the method may include calculating the total weight m c And update the parameter mean μ c , covariance∑ c and the score of each cluster Π c The probability that each data point belongs to cluster c can be calculated using the following formula:
[0059] m c =∑ i r ic
[0060]
[0061] The method according to some embodiments further comprises iteratively repeating the above steps until the log-likelihood function of the model converges:
[0062]
[0063] Each data point is thereby assigned to a cluster.
[0064] In some cases, the classification model includes a density-based spatial clustering of applications with noise (DBSCAN) algorithm. DBSCAN groups data points together by density, where points with higher density form clusters. Details about DBSCAN can be found in, for example, Ester et al. (1996) Proceedings of the Second International Conference on Knowledge Discovery and Data. 96(34):226-231; it is incorporated herein by reference. In some cases, the classification model includes a K-means clustering algorithm. K-means clustering involves partitioning observations into clusters, where each observation belongs to a cluster with the nearest mean (e.g., centroid). Details about K-means clustering can be found in, for example, Lloyd, Stuart P. (1967) IEEE Transactions on Information Theory. 28(2):129-137; it is incorporated herein by reference. In other cases, the classification model includes a balanced iterative reduction and clustering (BIRCH) algorithm using a hierarchy. BIRCH is an unsupervised data mining algorithm for hierarchical clustering. Details about BIRCH can be found in Zhang et al. (1996) "ACM sigmod record (ACM sigmod record)". 25 (2): 103-114. In some embodiments, BIRCH can be used to supplement one or more other algorithms discussed herein. For example, in some embodiments, BIRCH is used to accelerate K-means clustering. In other embodiments, BIRCH is used to accelerate Gaussian mixture modeling, as described herein. In some versions, the classification model includes a spectral clustering algorithm. Spectral clustering involves using the eigenvalues of a similarity matrix. Details about spectral clustering can be found, for example, in Von Luxburg, U. (2007) "Statistics and computing (Statistics and computing)" 17: 395-416; it is incorporated herein by reference.
[0065] After generating the classification model, the method of the present disclosure includes applying the classification model to classify the analyte data into clusters. After the analyte data is classified, the method according to some versions may include evaluating the classification model, such as by comparing the classification with the basic fact data to evaluate the classification model. In some cases, the analyte data is classified via the method described herein including 90% or more of the analyte data associated with the clustering criteria being included in the cluster associated with the clustering criteria, such as 90% or more, and including 97% or more. In addition, the analyte data is classified via the method described herein and may involve excluding 85% or more of the analyte data not associated with the clustering criteria from the cluster associated with the clustering criteria, such as 90% or more, and including 92% or more. In some embodiments, the method includes generating one or more population clusters based on the analyte features in the sample. As used herein, a "population" or "subpopulation" of an analyte (such as a cell, nucleic acid or other particle) generally refers to a group of analytes having properties (such as optical properties, impedance properties or time properties) about one or more measurement parameters so that the measured parameter data forms clusters in the data space. In an embodiment, data is made up of signals from different parameters of any given number, such as 2 or more, 3 or more, 4 or more, 5 or more, 6 or more, 7 or more, 8 or more, 9 or more, 10 or more, and include 20 or more. Therefore, colonies are identified as clusters in data. On the contrary, each data cluster is usually interpreted as a colony corresponding to a cell or analyte of a particular type, although clusters corresponding to noise or background are also usually observed. Clusters can be defined in a subset of dimensions (e.g., with respect to a subset of measured parameters), corresponding to colonies that are different only in a subset of measured parameters or features extracted from the measurement of cells, particles or nucleic acids.
[0066] In an embodiment, the method includes receiving data, calculating parameters of each analyte, and clustering the analytes based on the calculated parameters. For example, in the case where the data is flow cytometer data, the experiment can include particles labeled by several fluorophores or fluorescently labeled antibodies, and the group of particles can be defined by a group corresponding to one or more fluorescence measurements. In an example, the first group can be defined by a specific light scattering range of the first fluorophore, and the second group can be defined by a specific light scattering range of the second fluorophore. If the first fluorophore and the second fluorophore are represented on the x-axis and y-axis, respectively, if the information is graphically displayed, two different color-coded groups may appear to define each group of particles. Any number of analytes can be assigned to clusters, including 5 or more analytes, such as 10 or more analytes, such as 50 or more analytes, such as 100 or more analytes, such as 500 analytes and including 1000 analytes. In certain embodiments, the method groups together clustered rare events (e.g., rare cells in a sample, such as cancer cells) detected in a sample. In these embodiments, the generated analyte clusters may include 10 or fewer designated analytes, such as 9 or fewer and including 5 or fewer designated analytes.
[0067] Figure 1 A flow chart for practicing a method according to an embodiment of the present disclosure is shown. Figure 1 As shown, step 101 includes applying a regression model to determine a relationship between an initial set of analyte features and a clustering criterion. Step 102 involves generating a sparse set from at most a portion of the initial set of analyte features based on the relationship. Step 103 involves generating a classification model based on the sparse set. Step 104 involves applying the classification model to classify the analyte data into clusters.
[0068] In some cases, the methods of the present disclosure may be implemented in conjunction with the methods described in U.S. Provisional Patent Application No. 63 / 569,559 (Attorney Docket No. BECT-367PRV), filed on March 25, 2024; the disclosure of which is incorporated herein by reference in its entirety. In such cases, the computer-implemented method may include generating a predicted class for the analyte data using a decision tree ensemble, classifying the analyte data based on analyte features associated therewith, and refining the classified analyte data based on the analyte features and the predicted class using a distance-based classification model to classify the analyte data.
[0069] In some instances, the sample analyzed in the present method is a biological sample. The term "biological sample" is used with its conventional meaning, refers to a subset of a complete organism, plant, fungus or animal tissue, cell or component, which can be found in blood, mucus, lymph, synovial fluid, cerebrospinal fluid, saliva, bronchoalveolar lavage fluid, amniotic fluid, cord blood, urine, vaginal fluid and semen in some instances. Therefore, "biological sample" refers to a subset of natural organisms or its tissues and refers to a homogenate, lysate or extract prepared from a subset of an organism or its tissues, including but not limited to, for example, plasma, serum, cerebrospinal fluid, lymph, skin slices, respiratory slices, gastrointestinal slices, cardiovascular slices and urogenital tract slices, tears, saliva, milk, blood cells, tumors, organs. Biological sample can be any type of organic tissue, including both healthy tissue and diseased tissue (e.g., cancerous, malignant, necrotic, etc.). In certain embodiments, the biological sample is a liquid sample, such as blood or a derivative thereof, such as plasma, tears, urine, semen, etc., wherein in some instances, the sample is a blood sample, including whole blood, such as blood obtained from a venipuncture or finger puncture (wherein the blood may or may not be combined with any reagents prior to assay, such as preservatives, anticoagulants, etc.).
[0070] In certain embodiments, the source of the sample is "mammal" or "mammalian", wherein these terms are widely used to describe organisms in the class Mammalia, including Carnivora (e.g., dogs and cats), Rodentia (e.g., mice, guinea pigs and rats) and Primates (e.g., humans, chimpanzees and monkeys). In some instances, the subject is a human. The method can be applied to samples obtained from males and females and subjects at any stage of development (i.e., newborns, infants, teenagers, adolescents, adults), wherein in certain embodiments, human subjects are teenagers, adolescents or adults. Although the present disclosure can be applied to samples from human subjects, it should be understood that the method can also be implemented on samples from other animal subjects (i.e., in "non-human subjects") such as, but not limited to, birds, mice, rats, dogs, cats, livestock and horses.
[0071] The cell of interest can be targeted for characterization according to various parameters, such as phenotypic characteristics identified via attachment of specific fluorescent markers to the cell of interest. In some embodiments, the system is configured to deflect the droplet determined to include the analysis of the target cell. The subject method can be used to characterize a variety of cells. The target cell of interest includes but is not limited to stem cells, T cells, dendritic cells, B cells, granulocytes, leukemia cells, lymphoma cells, viral cells (such as HIV cells), NK cells, macrophages, monocytes, fibroblasts, epithelial cells, endothelial cells and erythrocytes. The target cell of interest includes a cell with a convenient cell surface marker or antigen, which can be captured or labeled by a convenient affinity reagent or its conjugate. For example, the target cell may include cell surface antigens such as CD11b, CD123, CD14, CD15, CD16, CD19, CD193, CD2, CD25, CD27, CD3, CD335, CD36, CD4, CD43, CD45RO, CD56, CD61, CD7, CD8, CD34, CD1c, CD23, CD304, CD235a, T cell receptor α / β, T cell receptor γ / δ, CD253, CD95, CD20, CD105, CD117, CD120b, Notch4, Lgr5 (N terminus), SSEA-3, TRA-1-60 antigen, disialoganglioside GD2, and CD71. In some embodiments, the target cell is selected from cells containing HIV, Treg cells, antigen-specific T cell populations, tumor cells, or hematopoietic progenitor cells (CD34+) from whole blood, bone marrow, or umbilical cord blood.
[0072] When practicing the subject method, a certain amount of initial fluid sample is injected into the flow cytometer. The amount of sample injected into the particle sorting module can vary, for example, ranging from 0.001 mL to 1000 mL, such as 0.005 mL to 900 mL, such as 0.01 mL to 800 mL, such as 0.05 mL to 700 mL, such as 0.1 mL to 600 mL, such as 0.5 mL to 500 mL, such as 1 mL to 400 mL, such as 2 mL to 300 mL and including 5 mL to 100 mL of sample.
[0073] The method according to the embodiment of the present disclosure includes counting and optionally sorting the labeled particles (e.g., target cells) in the sample. When practicing the subject method, a fluid sample containing particles is first introduced into the flow nozzle of the system. When leaving the flow nozzle, the particles pass through the sample query area substantially one at a time, where each particle is irradiated to the light source at the query area, and the measured values of the light scattering parameters are recorded for each particle, and the required fluorescence emission (e.g., the measured values of two or more light scattering parameters and one or more fluorescence emissions) are recorded in some instances. Depending on the nature of the flow stream being queried, 0.001 mm or more of the flow stream can be irradiated with light, such as 0.005 mm or more, such as 0.01 mm or more, such as 0.05 mm or more, such as 0.1 mm or more, such as 0.5 mm or more, and including 1 mm or more of the flow stream can be irradiated with light. In certain embodiments, the method includes, for example, irradiating a plane cross section of the flow stream in the sample query area with a laser (as described above). In other embodiments, the method includes irradiating a predetermined length of the flow stream in the sample query area, such as corresponding to the irradiation profile of a diffuse laser beam or lamp.
[0074] In certain embodiments, the method includes irradiating the flow stream at or near the flow cell nozzle orifice. For example, the method can include irradiating the flow stream at a distance of about 0.001 mm or more from the nozzle orifice, such as 0.005 mm or more, such as 0.01 mm or more, such as 0.05 mm or more, such as 0.1 mm or more, such as 0.5 mm or more and including 1 mm or more from the nozzle orifice. In certain embodiments, the method includes irradiating the flow stream in close proximity to the flow cell nozzle orifice.
[0075] In an embodiment of the method, a detector such as a photomultiplier tube (PMT) is used to record light passing through each particle (in some cases referred to as forward light scattering), light reflected in the direction of the flow of particles passing through the sensing region orthogonal to the particles (in some cases referred to as orthogonal light scattering or side light scattering), and fluorescence emitted by the particles when the particles pass through the sensing region and are irradiated by the energy source (if the particles are labeled with fluorescent markers). Each of forward light scattering (FSC), side scattering (SSC) and fluorescent emission includes a separate parameter for each particle (or each "event"). Thus, for example, two, three or four parameters can be collected (and recorded) from particles labeled with two different fluorescent markers. As needed, the data recorded for each particle is analyzed in real time or stored in a data storage and analysis component (e.g., a computer).
[0076] In certain embodiments, particles are detected and uniquely identified by exposing the particles to excitation light and measuring the fluorescence of each particle in one or more detection channels, as desired. The fluorescence emitted in the detection channel for identifying the particle and the binding complex associated therewith can be measured after excitation with a single light source, or can be measured separately after excitation with different light sources. If a separate excitation light source is used to excite the particle markers, the markers can be selected so that all markers can be excited by each excitation light source used.
[0077] The method in some embodiments also includes, for example, using a computer to collect data, analyze and record, wherein multiple data channels record data from each detector for light scattering and fluorescence emitted by each particle when each particle passes through the sample query area of the particle sorting module. In these embodiments, analysis includes classifying and counting particles so that each particle exists as a collection of digital parameter values. The subject system can be configured to trigger under selected parameters so that particles of interest are distinguished from background and noise. "Trigger" refers to a preset threshold for detecting a parameter, and can be used as a means for detecting particles passing through a light source. Detection of an event exceeding the threshold of a selected parameter will trigger the collection of light scattering and fluorescence data of the particle. Data of particles or other components in the measured medium that cause a response below the threshold are not collected. The trigger parameter can be the detection of forward scattered light caused by the particle passing through the light beam. Then the flow cytometer detects and collects the light scattering and fluorescence data of the particle.
[0078] Based on the data collected for the entire population, specific subpopulations of interest are then further analyzed by "gating." In order to select the appropriate gate, the data is plotted so that the best possible separation of subpopulations is obtained. The procedure can be performed by plotting forward light scatter (FSC) relative to side (i.e., orthogonal) light scatter (SSC) on a two-dimensional dot plot. Subpopulations of particles (i.e., those cells within the gate) are then selected and particles that are not within the gate are excluded. If necessary, a gate can be selected by drawing a line around the desired subpopulation using a cursor on the computer screen. Then, by plotting other parameters of these particles (such as fluorescence), only those particles within the gate are further analyzed. If necessary, the above analysis can be configured to produce counts of particles of interest in the sample.
[0079] The method of interest may further include using particles in research, laboratory testing or therapy. In some embodiments, the subject method includes obtaining single cells prepared from a target fluid or tissue biological sample. For example, the subject method includes obtaining cells to be used as research or diagnostic samples of diseases such as cancer from a fluid or tissue sample. Similarly, the subject method includes obtaining cells to be used for therapy from a fluid or tissue sample. Cell therapy protocols are protocols in which living cell materials including, for example, cells and tissues can be prepared and introduced into a subject as a therapeutic treatment. Conditions that can be treated by administering flow cytometer-sorted samples include, but are not limited to, blood disorders, immune system disorders, organ damage, etc.
[0080] Typical cell therapy protocols may include the following steps: sample collection, cell separation, genetic modification, in vitro culture and amplification, cell harvesting, sample volume reduction and washing, biological preservation, storage and introduction of cells into a subject. The protocol may start with collecting living cells and tissues from the source tissue of the subject to produce a sample of cells and / or tissues. Samples may be collected via any suitable procedure, including, for example, applying a cell mobilization agent to the subject, extracting blood from the subject, removing bone marrow from the subject, etc. After collecting the sample, cell enrichment may be performed via several methods, including, for example, centrifugation-based methods, filtration-based methods, elutriation, magnetic separation methods, fluorescence-activated cell sorting (FACS), etc. In some cases, the enriched cells may be genetically modified by any convenient method (e.g., nuclease-mediated gene editing). Genetically modified cells may be cultured, activated and amplified in vitro. In some cases, cells are preserved, such as cryopreserved, and stored for future use, wherein the cells are thawed and then applied to the patient, such as cells may be infused into the patient.
[0081] system
[0082] Aspects of the present disclosure also include systems. A system of interest includes a memory operably coupled to a processor, wherein the memory includes instructions stored thereon that, when executed by the processor, cause the processor to implement the method of the present disclosure, namely, applying a regression model to determine a relationship between an initial set of analyte features and a clustering criterion, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and applying the classification model to classify analyte data into clusters.
[0083] The system may include a display and an operator input device. The operator input device may be, for example, a keyboard, a mouse, etc. The processing module includes a processor that can access a memory on which instructions for executing the steps of the subject method are stored. The processing module may include an operating system, a graphical user interface (GUI) controller, a system memory, a memory storage device and an input-output controller, a cache memory, a data backup unit, and many other devices. The processor may be a commercially available processor, or it may be one of other processors that are available or will be available. The processor executes the operating system, and the operating system interfaces with firmware and hardware in a well-known manner, and helps the processor coordinate and execute the functions of various computer programs, which can be written in various programming languages (e.g., Java, Perl, C++, Python, other high-level or low-level languages, and combinations thereof), as known in the art. The operating system typically collaborates with the processor to coordinate and execute the functions of other components of the computer. The operating system also provides scheduling, input-output control, file and data management, memory management, and communication control and related services according to known techniques. In some embodiments, the processor includes analog electronics that provide feedback control (e.g., such as negative feedback control).
[0084] The system memory can be any of a variety of known or future memory storage devices. Examples include any commonly available random access memory (RAM), magnetic media (e.g., resident hard disk or tape), optical media (e.g., read-write optical disk), flash memory device, or other memory storage device. The memory storage device can be any of a variety of known or future devices, including an optical disk drive, a tape drive, or a floppy disk drive. This type of memory storage device typically reads from and / or writes to a program storage medium (not shown), such as an optical disk. Any of these program storage media or other media currently in use or that may be developed later can be considered a computer program product. As will be understood, these program storage media typically store computer software programs and / or data. Computer software programs (also referred to as computer control logic) are typically stored in system memory and / or program storage devices used in conjunction with memory storage devices.
[0085] In some embodiments, a computer program product is described, including a computer usable medium having control logic (computer software program, including program code) stored therein. The control logic, when executed by a processor computer, causes the processor to perform the functions described herein. In other embodiments, some functions are implemented primarily in hardware using, for example, a hardware state machine. The implementation of a hardware state machine in order to perform the functions described herein will be apparent to those skilled in the relevant art.
[0086] The subject programmable logic may be implemented in any of a variety of devices, such as a specially programmed event processing computer, a wireless communication device, an integrated circuit device, etc. In some embodiments, the programmable logic may be executed by a specially programmed processor, which may include one or more processors, such as one or more digital signal processors (DSPs), configurable microprocessors, application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or other equivalent integrated or discrete logic circuits. A combination of computing devices, such as a combination of a DSP and a microprocessor, a plurality of microprocessors, a combination of one or more microprocessors with a DSP core, or any other such configuration of at least some data connections may implement one or more features described herein.
[0087] The memory may be any suitable device in which the processor can store and retrieve data, such as a magnetic, optical or solid-state storage device (including a disk or optical disk or tape or RAM, or any other suitable device, fixed or portable). The processor may include a general-purpose digital microprocessor that is appropriately programmed by a computer-readable medium carrying the necessary program code. The program may be provided to the processor remotely through a communication channel, or pre-stored in a computer program product (such as a memory or some other portable or fixed computer-readable storage medium) using any of those devices associated with the memory. For example, a disk or optical disk may carry the program and may be read by a disk writer / reader. The system of the present disclosure also includes programming, such as in the form of a computer program product, for practicing the algorithm of the method described above. The programming according to the present disclosure may be recorded on a computer-readable medium (such as any medium that can be directly read and accessed by a computer). Such media include, but are not limited to: magnetic storage media, such as floppy disks, hard disk storage media, and tapes; optical storage media, such as CD-ROMs; electrical storage media, such as RAM and ROMs; portable flash drives; and hybrids of these categories, such as magnetic storage media / optical storage media.
[0088] The processor may also access a communication channel to communicate with a user at a remote location. A remote location means that the user does not interact directly with the system, but instead relays input information to the input manager from an external device, such as a computer connected to a wide area network ("WAN"), a telephone network, a satellite network, or any other suitable communication channel, including a mobile phone (i.e., a smart phone).
[0089] In some embodiments, a system according to the present disclosure may be configured to include a communication interface. In some embodiments, the communication interface includes a receiver and / or a transmitter for communicating with a network and / or another device. The communication interface may be configured for wired or wireless communication, including but not limited to radio frequency (RF) communication (e.g., radio frequency identification (RFID), Zigbee communication protocol, Wi-Fi, infrared, wireless universal serial bus (USB), ultra-wideband (UWB), Communication protocols and cellular communications, such as Code Division Multiple Access (CDMA) or Global System for Mobile Communications (GSM).
[0090] In one embodiment, the communication interface is configured to include one or more communication ports, such as physical ports or interfaces, such as a USB port, a USB-C port, an RS-232 port, or any other suitable electrical connection port, to allow data communication between the subject system and other external devices, such as computer terminals configured for similar supplemental data communications (e.g., in a doctor's office or in a hospital environment).
[0091] In one embodiment, the communication interface is configured for infrared communication, communications or any other suitable wireless communication protocol to enable the subject system to communicate with other devices, such as computer terminals and / or networks, communication-enabled mobile phones, personal digital assistants, or any other communication devices that a user may use in conjunction with.
[0092] In one embodiment, the communication interface is configured to provide a connection for data transmission using Internet Protocol (IP) through a cellular telephone network, a short message service (SMS), a wireless connection to a personal computer (PC) on a local area network (LAN) connected to the Internet, or a Wi-Fi connection to the Internet at a Wi-Fi hotspot.
[0093] In one embodiment, the subject system is configured to communicate wirelessly with a server device via a communication interface, such as using, for example, 802.11 or The server device may be another portable device, such as a smart phone, a personal digital assistant (PDA), or a laptop computer; or a larger device, such as a desktop computer, an appliance, etc. In some embodiments, the server device has a display, such as a liquid crystal display (LCD), and an input device, such as a button, a keyboard, a mouse, or a touch screen.
[0094] In some embodiments, the communication interface is configured to automatically or semi-automatically transfer data stored in the subject system, such as data stored in the optional data storage unit, with a network or server device using one or more of the above-described communication protocols and / or mechanisms.
[0095] The output controller may include a controller for any of a variety of known display devices for presenting information to a user, whether the user is a person or a machine, whether local or remote. If one of the display devices provides visual information, the information can generally be logically and / or physically organized as an array of image elements. A graphical user interface (GUI) controller may include any of a variety of known or future software programs for providing a graphical input and output interface between the system and the user, and for processing user input. The functional elements of the computer may communicate with each other via a system bus. Some of these communications may be implemented in alternative embodiments using a network or other types of remote communications. The output manager may also provide information generated by the processing module to a user at a remote location, such as through the Internet, telephone, or satellite network, according to known techniques. The presentation of data by the output manager may be implemented according to various known techniques. As some examples, the data may include SQL, HTML, or XML documents, emails or other files, or other forms of data. The data may include an Internet URL address so that a user can retrieve additional SQL, HTML, XML, or other documents or data from a remote source. One or more platforms present in the subject system may be any type of known computer platform or a type to be developed in the future, although they will generally belong to a class of computers commonly referred to as servers. However, they may also be mainframe computers, workstations, or other computer types. They may be connected via any known or future type of cables or other communication systems (networked or otherwise), including wireless systems. They may be co-located, or they may be physically separate. A variety of operating systems may be used on any computer platform, possibly depending on the type and / or configuration of the computer platform chosen. Suitable operating systems include XP, 7. 8. 10. Android TM 、SGI Oracle wait.
[0096] In the embodiments, the system further includes a flow cytometer operably connected to the processor. The subject flow cytometer generally includes a flow cell. The flow cell of interest includes a cuvette configured to transport particles in a flow stream. As discussed herein, "flow cell" is described in its conventional sense and refers to a component comprising a flow channel for a liquid flow stream, which is used to transport particles in a sheath fluid. The cuvette of interest has a passage (i.e., a flow channel) running through it. The flow stream configured with the flow channel may include a liquid sample injected from a sample tube. In some instances, the flow cell includes a flow channel accessible to light. The cuvette may be composed of, for example, quartz, glass, transparent plastic, etc. In some embodiments, the cuvette is formed of silicon dioxide (e.g., fused silica). In some cases, the flow cell is configured to be irradiated with light from a light source at one or more query points. The "query point" discussed herein refers to an area within the flow cell where particles are irradiated with light from a light source, such as for analysis. The size of the query point can be varied as desired. For example, with 0 μm representing the optical axis of the light emitted by the light source, the query point may be in the range of -50 μm to 50 μm, such as -25 μm to 40 μm and including -15 μm to 30 μm. There may be multiple illumination points within the flow cell depending on certain considerations such as the number and arrangement of lasers.
[0097] In some embodiments, the flow cell includes or is configured for use with a sample injection port configured to provide a sample to the flow cell. In embodiments, the sample injection system is configured to provide a suitable sample flow to the flow cell chamber (i.e., flow channel). Depending on the desired characteristics of the flow stream, the rate at which the sample is delivered to the flow cell chamber through the sample injection port can be 1 μL / min or greater, such as 2 μL / min or greater, such as 3 μL / min or greater, such as 5 μL / min or greater, such as 10 μL / min or greater, such as 15 μL / min or greater, such as 25 μL / min or greater, such as 50 μL / min or greater and including 100 μL / min or greater, wherein in some instances, the rate at which the sample is delivered to the flow cell chamber through the sample injection port is 1 μL / sec or greater, such as 2 μL / sec or greater, such as 3 μL / sec or greater, such as 5 μL / sec or greater, such as 10 μL / sec or greater, such as 15 μL / sec or greater, such as 25 μL / sec or greater, such as 50 μL / sec or greater and including 100 μL / sec or greater.
[0098] The sample injection port can be an orifice positioned in the wall of the inner chamber, or can be a conduit positioned at the proximal end of the inner chamber. In the case where the sample injection port is an orifice positioned in the wall of the inner chamber, the sample injection port orifice can be any suitable shape, wherein the cross-sectional shape of interest includes but is not limited to: a straight cross-sectional shape (e.g., square, rectangular, trapezoidal, triangle, hexagonal, etc.), a curved cross-sectional shape (e.g., circular, elliptical, etc.) and an irregular shape (e.g., a parabolic bottom portion coupled to a planar top portion). In certain embodiments, the sample injection port has a circular orifice. The size of the sample injection port orifice can vary according to the shape, and in certain instances, has a range of 0.1mm to 5.0mm, such as 0.2 to 3.0mm, such as 0.5mm to 2.5mm, such as 0.75mm to 2.25mm, such as 1mm to 2mm and includes 1.25mm to 1.75mm, such as an opening of 1.5mm.
[0099] In some instances, the sample injection port is a conduit positioned at the proximal end of the flow cell chamber. For example, the sample injection port can be a conduit positioned so that the orifice of the sample injection port is in line with the orifice of the flow cell. In the case where the sample injection port is a conduit positioned in line with the orifice of the flow cell, the cross-sectional shape of the sample injection tube can be any suitable shape, wherein the cross-sectional shape of interest includes but is not limited to: a straight cross-sectional shape (e.g., square, rectangular, trapezoidal, triangle, hexagonal, etc.), a curved cross-sectional shape (e.g., circular, elliptical), and an irregular shape (e.g., a parabolic bottom portion coupled to a planar top portion). The orifice of the conduit can vary according to the shape, and in some instances, has a range of 0.1mm to 5.0mm, e.g., 0.2 to 3.0mm, e.g., 0.5mm to 2.5mm, e.g., 0.75mm to 2.25mm, e.g., 1mm to 2mm and includes 1.25mm to 1.75mm, e.g., an opening of 1.5mm. The shape of the tip of the sample injection port can be the same or different from the cross-sectional shape of the sample injection tube. For example, the orifice of the sample injection port may include a beveled tip having a bevel angle ranging from 1° to 10°, such as 2° to 9°, such as 3° to 8°, such as 4° to 7° and including a bevel angle of 5°.
[0100] In some embodiments, the flow cell further comprises a sheath liquid injection port configured to provide a sheath liquid to the flow cell. In an embodiment, the sheath liquid injection system is configured to provide a sheath liquid flow to the flow cell chamber, such as a laminar flow stream of sheath liquid combined with the sample to generate a sheath liquid around the sample flow stream. Depending on the desired characteristics of the flow stream, the rate of the sheath liquid delivered to the flow cell chamber can be 25 μL / sec or greater, such as 50 μL / sec or greater, such as 75 μL / sec or greater, such as 100 μL / sec or greater, such as 250 μL / sec or greater, such as 500 μL / sec or greater, such as 750 μL / sec or greater, such as 1000 μL / sec or greater and including 2500 μL / sec or greater.
[0101] In some embodiments, the sheath injection port is an orifice positioned in the wall of the inner chamber. The sheath injection port orifice can be any suitable shape, wherein the cross-sectional shapes of interest include, but are not limited to, a straight cross-sectional shape (e.g., square, rectangular, trapezoidal, triangular, hexagonal, etc.), a curved cross-sectional shape (e.g., circular, elliptical), and an irregular shape (e.g., a parabolic bottom portion coupled to a planar top portion). The size of the sheath injection port orifice can vary depending on the shape, and in some instances, has an opening ranging from 0.1 mm to 5.0 mm, such as 0.2 mm to 3.0 mm, such as 0.5 mm to 2.5 mm, such as 0.75 mm to 2.25 mm, such as 1 mm to 2 mm and including 1.25 mm to 1.75 mm, such as 1.5 mm.
[0102] The flow cytometer of the present disclosure includes a light source, which is configured to illuminate particles in the flow stream at a query point in the flow cell. The number of light sources in the flow cytometer can vary. In some embodiments, the flow cytometer includes a single light source. Alternatively, the flow cytometer may include multiple light sources in some instances. In some such instances, the number of light sources is 2 to 10, such as 2 to 5, and includes a range of 2 to 4. Any convenient light source can be used as the light source described herein. In some embodiments, the light source is a laser. In an embodiment, the laser can be any convenient laser, such as a continuous wave laser. For example, the laser can be a diode laser, such as an ultraviolet diode laser, a visible diode laser, and a near-infrared diode laser. In other embodiments, the laser can be a helium-neon (HeNe) laser. In some examples, the laser is a gas laser, such as a helium-neon laser, an argon laser, a krypton laser, a xenon laser, a nitrogen laser, a CO2 laser, a CO laser, an argon-fluorine (ArF) excimer laser, a krypton-fluorine (KrF) excimer laser, a xenon-chlorine (XeCl) excimer laser, or a xenon-fluorine (XeF) excimer laser, or a combination thereof. In other examples, the subject flow cytometer includes a dye laser, such as a stilbene laser, a coumarin laser, or a rhodamine laser. In other examples, the laser of interest includes a metal vapor laser, such as a helium-cadmium (HeCd) laser, a helium-mercury (HeHg) laser, a helium-selenium (HeSe) laser, a helium-silver (HeAg) laser, a strontium laser, a neon-copper (NeCu) laser, a copper laser, or a gold laser, and combinations thereof. In other examples, the subject flow cytometer includes a solid-state laser, such as a ruby laser, a Nd:YAG laser, a NdCrYAG laser, an Er:YAG laser, a Nd:YLF laser, a Nd:YVO4 laser, a Nd:YCa4O(BO3)3 laser, a Nd:YCOB laser, a titanium sapphire laser, a thulium YAG laser, an ytterbium YAG laser, an yttrium oxide laser, or a cerium-doped laser, and combinations thereof.
[0103] According to certain embodiments, the laser light source may further include one or more optical adjustment components. In certain embodiments, the optical adjustment component is located between the light source and the flow cell, and may include any device capable of changing the spatial width of the irradiation from the light source or some other irradiation characteristics (e.g., such as irradiation direction, wavelength, beam width, beam intensity, and focus). The optical adjustment scheme may include any convenient device for adjusting one or more characteristics of the light source, including but not limited to lenses, reflectors, filters, optical fibers, wavelength separators, pinholes, slits, collimation schemes, and combinations thereof. In certain embodiments, the flow cytometer of interest includes one or more focusing lenses. In one example, the focusing lens may be a reduction lens. In other embodiments, the flow cytometer of interest includes an optical fiber.
[0104] The light source can be located at any suitable distance from the flow cell, for example, wherein the light source and the flow cell are separated by 0.005 mm or more, for example, 0.01 mm or more, for example, 0.05 mm or more, for example, 0.1 mm or more, for example, 0.5 mm or more, for example, 1 mm or more, for example, 5 mm or more, for example, 10 mm or more, for example, 25 mm or more and including a distance of 100 mm or more. In addition, the light source can be positioned at any suitable angle relative to the flow cell, for example, with an angle in the range of 10 to 90 degrees, for example, 15 to 85 degrees, for example, 20 to 80 degrees, for example, 25 to 75 degrees and including 30 to 60 degrees, for example, at an angle of 90 degrees.
[0105] In some embodiments, the light source of interest includes multiple lasers configured to provide laser light for discrete irradiation of the flow stream, such as 2 or more lasers, such as 3 or more lasers, such as 4 or more lasers, such as 5 or more lasers, such as 10 or more lasers, and including 15 or more lasers configured to provide laser light for discrete irradiation of the flow stream. Depending on the wavelength of light required for irradiating the flow stream, each laser can have a specific wavelength ranging from 200nm to 1500nm, such as from 250nm to 1250nm, such as from 300nm to 1000nm, such as from 350nm to 900nm and including from 400nm to 800nm. In certain embodiments, the laser of interest can include one or more of a 405nm laser, a 488nm laser, a 561nm laser, and a 635nm laser.
[0106] In some embodiments, the light source is a beam generator configured to generate two or more frequency-shifted beams. In some instances, the beam generator includes a laser, a radio frequency generator configured to apply a radio frequency drive signal to the acousto-optic device to generate two or more angularly deflected laser beams. In these embodiments, the laser can be a pulsed laser or a continuous wave laser. For example, the laser in the beam generator of interest can be a gas laser, such as a helium-neon laser, an argon laser, a krypton laser, a xenon laser, a nitrogen laser, a CO2 laser, a CO laser, an argon-fluorine (ArF) excimer laser, a krypton-fluorine (KrF) excimer laser, a xenon-chlorine (XeCl) excimer laser, or a xenon-fluorine (XeF) excimer laser, or a combination thereof; a dye laser, such as a stilbene laser, a coumarin laser, or a rhodamine laser; a metal vapor laser, such as a helium-cadmium (HeCd) laser, a helium-mercury (HeHg) laser, a helium-selenium ( solid-state lasers, such as ruby lasers, Nd:YAG lasers, NdCrYAG lasers, Er:YAG lasers, Nd:YLF lasers, Nd:YVO4 lasers, Nd:YCa4O(BO3)3 lasers, Nd:YCOB lasers, titanium sapphire lasers, thulium YAG lasers, ytterbium YAG lasers, yttrium oxide lasers or cerium-doped lasers, and combinations thereof.
[0107] The acousto-optic device can be any convenient acousto-optic scheme that is configured to frequency shift the laser using an applied acoustic wave. In certain embodiments, the acousto-optic device is an acousto-optic deflector. The acousto-optic device in the subject system is configured to generate an angularly deflected laser beam from light from a laser and an applied RF drive signal. The RF drive signal can be applied to the acousto-optic device using any suitable RF drive signal source (e.g., a direct digital synthesizer (DDS), any waveform generator (AWG), or an electrical pulse generator).
[0108] In an embodiment, the controller is configured to apply a radio frequency drive signal to the acousto-optic device to generate a desired number of angularly deflected laser beams in the output laser beam, for example, configured to apply 3 or more radio frequency drive signals, for example, 4 or more radio frequency drive signals, for example, 5 or more radio frequency drive signals, for example, 6 or more radio frequency drive signals, for example, 7 or more radio frequency drive signals, for example, 8 or more radio frequency drive signals, for example, 9 or more radio frequency drive signals, for example, 10 or more radio frequency drive signals, for example, 15 or more radio frequency drive signals, for example, 25 or more radio frequency drive signals, for example, 50 or more radio frequency drive signals, and including being configured to apply 100 or more radio frequency drive signals.
[0109] In some examples, to generate an intensity profile of an angularly deflected laser beam in the output laser beam, the controller is configured to apply a radio frequency drive signal with a varying amplitude, for example, from about 0.001 V to about 500 V, for example, from about 0.005 V to about 400 V, for example, from about 0.01 V to about 300 V, for example, from about 0.05 V to about 200 V, for example, from about 0.1 V to about 100 V, for example, from about 0.5 V to about 75 V, for example, from about 1 V to 50 V, for example, from about 2 V to 40 V, for example, from 3 V to about 30 V and including from about 5 V to about 25 V. In some embodiments, each applied RF drive signal has a frequency of about 0.001 MHz to about 500 MHz, such as about 0.005 MHz to about 400 MHz, such as about 0.01 MHz to about 300 MHz, such as about 0.05 MHz to about 200 MHz, such as about 0.1 MHz to about 100 MHz, such as about 0.5 MHz to about 90 MHz, such as about 1 MHz to about 75 MHz, such as about 2 MHz to about 70 MHz, such as about 3 MHz to about 65 MHz, such as about 4 MHz to about 60 MHz and including about 5 MHz to about 50 MHz.
[0110] In certain embodiments, the controller has a processor having a memory operably coupled to the processor such that the memory includes instructions stored thereon that, when executed by the processor, cause the processor to generate an output laser beam of an angularly deflected laser beam having a desired intensity profile. For example, the memory may include instructions to generate two or more angularly deflected laser beams having the same intensity, such as 3 or more, such as 4 or more, such as 5 or more, such as 10 or more, such as 25 or more, such as 50 or more, and including instructions that the memory may include instructions to generate 100 or more angularly deflected laser beams having the same intensity. In other embodiments, the memory may include instructions to generate two or more angularly deflected laser beams having different intensities, such as 3 or more, such as 4 or more, such as 5 or more, such as 10 or more, such as 25 or more, such as 50 or more, and including instructions that the memory may include instructions to generate 100 or more angularly deflected laser beams having different intensities.
[0111] In certain embodiments, the controller has a processor having a memory operably coupled to the processor such that the memory includes instructions stored thereon that, when executed by the processor, cause the processor to generate an output laser beam having an intensity that increases from an edge to a center of the output laser beam along a horizontal axis. In these examples, the intensity of the angularly deflected laser beam at the center of the output beam can be in the range of 0.1% to about 99%, such as 0.5% to about 95%, such as 1% to about 90%, such as about 2% to about 85%, such as about 3% to about 80%, such as about 4% to about 75%, such as about 5% to about 70%, such as about 6% to about 65%, such as about 7% to about 60%, such as about 8% to about 55% of the intensity of the angularly deflected laser beam at the edge of the output laser beam along the horizontal axis, and includes about 10% to about 50% of the intensity of the angularly deflected laser beam at the edge of the output laser beam along the horizontal axis. In other embodiments, the controller has a processor having a memory operably coupled to the processor such that the memory includes instructions stored thereon that, when executed by the processor, cause the processor to generate an output laser beam having an intensity that increases from an edge to a center of the output laser beam along the horizontal axis. In these examples, the intensity of the angularly deflected laser beam at the edge of the output beam can be in the range of 0.1% to about 99%, such as 0.5% to about 95%, such as 1% to about 90%, such as about 2% to about 85%, such as about 3% to about 80%, such as about 4% to about 75%, such as about 5% to about 70%, such as about 6% to about 65%, such as about 7% to about 60%, such as about 8% to about 55%, of the intensity of the angularly deflected laser beam at the center of the output laser beam along the horizontal axis, and includes about 10% to about 50% of the intensity of the angularly deflected laser beam at the center of the output laser beam along the horizontal axis. In other embodiments, the controller has a processor having a memory operably coupled to the processor such that the memory includes instructions stored thereon that, when executed by the processor, cause the processor to generate an output laser beam having an intensity profile of a Gaussian distribution along a horizontal axis. In other embodiments, the controller has a processor having a memory operably coupled to the processor such that the memory includes instructions stored thereon that, when executed by the processor, cause the processor to generate an output laser beam having an intensity profile of a top-hat distribution along a horizontal axis.
[0112] In an embodiment, the beam generator of interest can be configured to generate spatially separated angularly deflected laser beams in the output laser beam. Depending on the applied RF drive signal and the desired irradiation profile of the output laser beam, the angularly deflected laser beams can be separated by 0.001 μm or more, such as 0.005 μm or more, such as 0.01 μm or more, such as 0.05 μm or more, such as 0.1 μm or more, such as 0.5 μm or more, such as 1 μm or more, such as 5 μm or more, such as 10 μm or more, such as 100 μm or more, such as 500 μm or more, such as 1000 μm or more and including 5000 μm or more. In some embodiments, the system is configured to generate angularly deflected laser beams in the output laser beam, which angularly deflected laser beams overlap, such as overlapping with adjacent angularly deflected laser beams along the horizontal axis of the output laser beam. The overlap between adjacent angularly deflected laser beams (e.g., the overlap of beam spots) can be an overlap of 0.001 μm or greater, for example, an overlap of 0.005 μm or greater, for example, an overlap of 0.01 μm or greater, for example, an overlap of 0.05 μm or greater, for example, an overlap of 0.1 μm or greater, for example, an overlap of 0.5 μm or greater, for example, an overlap of 1 μm or greater, for example, an overlap of 5 μm or greater, for example, an overlap of 10 μm or greater and including an overlap of 100 μm or greater.
[0113] In some instances, a beam generator configured to generate two or more frequency-shifted beams includes a laser excitation module as described in U.S. Patent Nos. 9,423,353; 9,784,661 and 10,006,852 and U.S. Patent Publication Nos. 2017 / 0133857 and 2017 / 0350803, the disclosures of which are incorporated herein by reference.
[0114] In addition, the flow cytometer includes a detector configured to collect light emitted by the irradiated particles. The light detector is configured to detect the particle modulated light transmitted by the fiber optic light collecting element and generate a signal based on the characteristics of the light (e.g., intensity). For example, one or more particle modulated light detectors may include one or more side scattering light detectors for detecting the side scattering wavelength of light (i.e., light refracted and reflected from the surface and internal structure of the particles). In some embodiments, the flow cytometer includes a single side scattering light detector. In other embodiments, the flow cytometer includes multiple side scattering light detectors, such as 2 or more, such as 3 or more, such as 4 or more, and including 5 or more.
[0115] Any convenient detector for detecting the collected light can be used in the side scattered light detector described herein. Detectors of interest can include, but are not limited to, optical sensors or detectors, such as active pixel sensors (APS), avalanche photodiodes, image sensors, charge coupled devices (CCD), enhanced charge coupled devices (ICCD), light emitting diodes, photon counters, irradiance calorimeters, pyroelectric detectors, photoresistors, photovoltaic cells, photodiodes, photomultiplier tubes (PMTs), phototransistors, quantum dot photoconductors or photodiodes and combinations thereof, and other detectors. In certain embodiments, the collected light is measured with a charge coupled device (CCD), a semiconductor charge coupled device (CCD), an active pixel sensor (APS), a complementary metal oxide semiconductor (CMOS) image sensor, or an N-type metal oxide semiconductor (NMOS) image sensor. In certain embodiments, the detector is a photomultiplier tube, such as an effective detection surface area range of 0.01 cm per region. 2 Up to 10cm 2 , for example 0.05cm 2 Up to 9cm 2 , for example 0.1cm 2 Up to 8cm 2 , for example 0.5cm 2 Up to 7cm 2 And including 1cm 2 Up to 5cm 2 Photomultiplier tube.
[0116] In embodiments, the subject flow cytometer further comprises a fluorescence detector configured to detect light of one or more fluorescence wavelengths. In other embodiments, the flow cytometer comprises a plurality of fluorescence detectors, such as 2 or more, such as 3 or more, such as 4 or more, 5 or more, 10 or more, 15 or more, and including 20 or more.
[0117] Any convenient detector for detecting the collected light can be used in the fluorescence detectors described herein. Detectors of interest can include, but are not limited to, optical sensors or detectors, such as active pixel sensors (APS), avalanche photodiodes, image sensors, charge coupled devices (CCD), enhanced charge coupled devices (ICCD), light emitting diodes, photon counters, irradiance calorimeters, pyroelectric detectors, photoresistors, photovoltaic cells, photodiodes, photomultiplier tubes (PMTs), phototransistors, quantum dot photoconductors or photodiodes and combinations thereof, and other detectors. In certain embodiments, the collected light is measured with a charge coupled device (CCD), a semiconductor charge coupled device (CCD), an active pixel sensor (APS), a complementary metal oxide semiconductor (CMOS) image sensor, or an N-type metal oxide semiconductor (NMOS) image sensor. In certain embodiments, the detector is a photomultiplier tube, such as an effective detection surface area range of 0.01 cm per region. 2 Up to 10cm 2 , for example 0.05cm 2 Up to 9cm 2 , for example 0.1 cm 2 Up to 8cm 2 , for example 0.5cm 2 Up to 7cm 2 And including 1cm 2 Up to 5cm 2 Photomultiplier tube.
[0118] In the case where the subject flow cytometer includes multiple fluorescence detectors, each fluorescence detector can be the same, or the collection of fluorescence detectors can be a combination of different types of detectors. For example, in the case where the subject flow cytometer includes two fluorescence detectors, in some embodiments, the first fluorescence detector is a CCD type device, and the second fluorescence detector (or imaging sensor) is a CMOS type device. In other embodiments, both the first fluorescence detector and the second fluorescence detector are CCD type devices. In other embodiments, both the first fluorescence detector and the second fluorescence detector are CMOS type devices. In other embodiments, the first fluorescence detector is a CCD type device, and the second fluorescence detector is a photomultiplier tube (PMT). In other embodiments, the first fluorescence detector is a CMOS type device, and the second fluorescence detector is a photomultiplier tube. In other embodiments, both the first fluorescence detector and the second fluorescence detector are photomultiplier tubes.
[0119] In embodiments of the present disclosure, the fluorescence detector of interest is configured to measure the collected light at one or more wavelengths, such as at 2 or more wavelengths, such as at 5 or more different wavelengths, such as at 10 or more different wavelengths, such as at 25 or more different wavelengths, such as at 50 or more different wavelengths, such as at 100 or more different wavelengths, such as at 200 or more different wavelengths, such as at 300 or more different wavelengths, and including measuring light emitted by a sample in a flow stream at 400 or more different wavelengths. In some embodiments, 2 or more detectors in a module as described herein are configured to measure the same or overlapping wavelengths of collected light.
[0120] In some embodiments, the fluorescence detector of interest is configured to measure the light collected within a certain wavelength range (e.g., 200nm-1000nm). In certain embodiments, the detector of interest is configured to collect the spectrum within a certain wavelength range. For example, a flow cytometer may include one or more detectors configured to collect the spectrum within one or more wavelength ranges of 200nm-1000nm. In other embodiments, the detector of interest is configured to measure the light emitted by the sample in the flow stream at one or more specific wavelengths. For example, a module may include one or more detectors configured to measure light at one or more locations in 450nm, 518nm, 519nm, 561nm, 578nm, 605nm, 607nm, 625nm, 650nm, 660nm, 667nm, 670nm, 668nm, 695nm, 710nm, 723nm, 780nm, 785nm, 647nm, 617nm and any combination thereof. In certain embodiments, one or more detectors can be configured to pair with a specific fluorophore (eg, a fluorophore to be used with a sample in a fluorescence assay).
[0121] The flow cytometer can include any suitable mechanism for providing sheath fluid and sample fluid to the sample fluid input coupler and the sheath fluid input coupler. For example, the sample fluid input coupler can be fluidically connected to a sample fluid line (e.g., a pipe) that is fluidically connected to a sample fluid reservoir. Similarly, the sheath fluid input coupler can be fluidically connected to a sheath fluid line that is fluidically connected to a sheath fluid reservoir. Similarly, the flow cytometer can include any suitable mechanism for managing waste from the flow stream. The fluid output coupler can be fluidically connected to a waste line that is fluidically connected to a waste reservoir. A fluid management system applicable to a subject flow cytometer is provided in U.S. Patent Application Publication No. 2022 / 0341838, the disclosure of which is incorporated herein by reference in its entirety.
[0122] Suitable flow cytometry systems may include, but are not limited to, those described in Ormerod (ed.), Flow Cytometry: A Practical Approach, Oxford Univ. Press (1997); Jaroszeski et al. (eds.), Flow Cytometry Protocols, Methods in Molecular Biology 91, Humana Press (1997); Practical Flow Cytometry, 3rd ed., Wiley-Liss (1995); Virgo et al. (2012) Ann Clin Biochem. Jan;49(pt 1):17-28; Linden et al. Semin Throm Hemost. Oct 2004;30(5):502-11; Alison et al. J Pathol. Pathol., Dec. 2010; 222(4):335-344; and Herbig et al. (2007) Crit Rev Ther Drug Carrier Syst. 24(3):203-255; the disclosures of which are incorporated herein by reference. In certain instances, the flow cytometry system of interest includes the BD Biosciences FACSCanto TM Flow cytometer, BD Biosciences FACSCanto TM II flow cytometer, BD Accuri TM Flow cytometer, BD Accuri TM C6+ flow cytometer, BD Biosciences FACSCelesta TM Flow cytometer, BD Biosciences FACSLyric TM Flow cytometer, BD Biosciences FACSVerse TM Flow cytometer, BD Biosciences FACSymphony TM Flow cytometer, BD Biosciences LSRFortessa TM Flow cytometer, BD Biosciences LSRFortessa TMX-20 flow cytometer, BD Biosciences FACSPresto TM Flow cytometer, BD Biosciences FACSVia TM Flow cytometer and BD Biosciences FACSCalibur TM Cell sorter, BD Biosciences FACSCount TM Cell sorter, BD Biosciences FACSLyric TM Cell sorter, BD Biosciences Via TM Cell sorter, BD Biosciences Influx TM Cell sorter, BD Biosciences Jazz TM Cell sorter, BD Biosciences Aria TM Cell sorter, BD Biosciences FACSAria TM II cell sorter, BD Biosciences FACSAria TM III cell sorter, BD Biosciences FACSAria TM Fusion Cell Sorter and BD Biosciences FACSMelody TM Cell sorter, BD Biosciences FACSymphony TM S6 cell sorter, BD Biosciences FACSDiscover TM Cell sorter, etc.
[0123] In some embodiments, the subject system is a flow cytometry system, such as described in U.S. Pat. Nos. 10,663,476; 10,620,111; 10,613,017; 10,605,713; 10,585,031; 10,578,542; 10,578,469; 10,481,074; 10,302,545; 10,145,793; 10,113,967; 10,006,852; 9,952,076; 9,933,341; 9,726,527; 9,453,789; 9,200,334; 9,097,640; 9, those described in 095,494; 9,092,034; 8,975,595; 8,753,573; 8,233,146; 8,140,300; 7,544,326; 7,201,875; 7,129,505; 6,821,740; 6,813,017; 6,809,804; 6,372,506; 5,700,692; 5,643,796; 5,627,040; 5,620,842; 5,602,039; 4,987,086; 4,498,766; the disclosures of which are incorporated herein by reference in their entireties.
[0124] In some embodiments, the flow cytometer is configured as an imaging flow cytometer. For example, in some instances, the subject system is a flow cytometer system configured for imaging particles in a flow stream by fluorescence imaging using radio frequency label emission (FIRE), such as those described in Diebold et al., Nature Photonics, Vol. 7 (10); 806-810 (2013) and U.S. Patent Nos. 9,423,353; 9,784,661 and 10,006,852 and U.S. Patent Application Publication Nos. 2017 / 0133857 and 2017 / 0350803, the disclosures of which are incorporated herein by reference. In some embodiments where the flow cytometer is a particle sorter, the particle sorter is an image-enabled particle sorter. Image-enabled particle sorters are described in US Provisional Patent Application Nos. 63 / 431,803 and 63 / 465,057; the disclosures of which are incorporated herein by reference in their entireties.
[0125] Figure 2 A system 200 for flow cytometry is shown according to an illustrative embodiment of the present disclosure. The system 200 includes a laser 201 configured to illuminate particles 211 in a flow stream 214 at a query point 215 within a flow cell 210. Figure 2The example of shows a single laser, but it will be appreciated that multiple lasers may also be used. The laser beam from laser 201 is directed to a focusing lens 202 which focuses the beam onto a portion of the flow stream within a flow cell 210 where particles 211 of the sample are located. The flow cell 210 is part of a fluidic system that directs particles in the stream to a focused laser beam for interrogation, typically one particle at a time. Alternatively, in the case where the flow cytometer is a flow-in-air cytometer, a nozzle top may be used.
[0126] like Figure 2 As shown, the flow cell 210 is fluidically connected to a sheath fluid reservoir 203 containing a sheath fluid and a sample fluid reservoir 204 containing a sample fluid. The sheath fluid from the sheath fluid reservoir 203 is provided to at least one sheath fluid injection port 208 via a conduit (i.e., a sheath fluid line) 207. In addition, the sample fluid containing particles 211 from the sample fluid reservoir 204 is provided to the sample injection port 206 via a conduit (i.e., a sample fluid line) 205. The sample injection port 206 is fluidically connected to a sample injector 213 (e.g., a sample injection needle), which is configured to introduce the particles 211 into the interior of the flow cell 210. The particles 211 are hydrodynamically focused via the sheath fluid entering from the sheath fluid injection port 208, so that a flow stream 214 is formed downstream of the tapered portion 212 of the flow cell 210. The particles emitted at the distal end of the flow cell 210 can be disposed and / or collected via any suitable scheme. For example, depending on the type of flow cytometry being performed, the particles may be collected at the distal end of the flow cell 210, such as via a waste line. Alternatively, the particles may be sorted.
[0127] The light from the laser beam interacts with the particles 211 in the sample by diffraction, refraction, reflection, scattering and absorption, and re-emitted at various wavelengths according to the characteristics of the particles, such as their size, internal structure and the presence of one or more fluorescent molecules attached to or naturally present on or in the particles. Fluorescence emission and diffracted light, refracted light, reflected light and scattered light can be routed to one or more detectors. In particular, forward scattered light (FSC) is routed to forward scattered light detector 223. Forward scattered light detector 223 is positioned to slightly deviate from the axis of the direct light beam passing through flow cell 210, and is configured to detect diffracted light, i.e., excitation light that passes through or travels around particles mainly in the forward direction. The intensity of the light detected by forward scattered light detector 223 depends on the overall size of the particles. The forward scattered detector can include, for example, a photodiode. Filter 221a and scattering strip 222 are located between forward scattered light detector 223. The filter 221 a may be configured to filter out at least one wavelength of non-FSC light, and the scattering strip 222 may be configured to prevent an incident light beam (ie, non-scattered light) from the laser 201 from being detected by the forward scattered light detector 223 .
[0128] In addition, side scattered light (SSC) is detected by side scattered light detector 224. In other words, side scattered light detector 224 is configured to detect refracted and reflected light from the surface and internal structure of particle 211, which tends to increase with the increase of particle structure complexity. Figure 2 In the example of , the flow cytometer 200 includes a dichroic mirror 220a, which is configured to reflect SSC light to a side scattered light detector 224 while allowing non-SSC (e.g., fluorescence) light to pass. The filter 221b is configured to prevent at least one wavelength of non-SSC light from being detected by the side scattered light detector 224. Fluorescence detectors 225a-225c are also shown, each of which is configured to detect fluorescence of a different wavelength. For example, the dichroic mirror 220b can be configured to reflect fluorescence (FL) corresponding to a first wavelength (or wavelength range) to the fluorescence detector 225a while allowing light of other wavelengths to pass. The filter 221c can be configured to prevent at least one wavelength of light that does not correspond to the first wavelength (or wavelength range) from being detected by the fluorescence detector 225a. Similarly, the dichroic mirror 220c is configured to reflect FL light corresponding to a second wavelength (or wavelength range) to the fluorescence detector 225b while allowing light of a third wavelength (or wavelength range) to pass for detection by the fluorescence detector 225c. The filter 221d is configured to prevent light of at least one wavelength that does not correspond to the second wavelength (or wavelength range) from being detected by the fluorescence detector 225b. In addition, the filter 221e is configured to prevent light of at least one wavelength that does not correspond to the third wavelength (or wavelength range) from being detected by the fluorescence detector 225c.
[0129] Those skilled in the art will recognize that flow cytometers according to embodiments of the present disclosure are not limited to Figure 2 The flow cytometer shown may include any flow cytometer known in the art. For example, the flow cytometer may have any number of lasers, beam splitters, filters, and detectors at various wavelengths and in various configurations. For example, although Figure 2 The embodiment of FIG. 5 shows three fluorescence detectors for illustrative purposes, but it will be appreciated that any suitable number of fluorescence detectors may be employed.
[0130] In operation, the blood cell counter operation is controlled by the controller / processor 290, and the measurement data from the detector can be stored in the memory 295 and processed by the controller / processor 290. Although not explicitly shown, the controller / processor 290 is coupled to the detector to receive the output signal from the detector, and can also be coupled to the electrical and electromechanical components of the flow cytometer to control the laser 201, fluid flow parameters, etc. Input / output (I / O) capabilities 297 can also be provided in the system. The memory 295, the controller / processor 290 and the I / O 297 can be provided entirely as an integral part of the flow cytometer. In such embodiments, the display can also form part of the I / O capabilities 297 for presenting experimental data to the user of the blood cell counter 200. Alternatively, some or all of the memory 295 and the controller / processor 290 and the I / O capabilities can be part of one or more external devices such as a general-purpose computer. In some embodiments, some or all of the memory 295 and the controller / processor 290 can communicate wirelessly or wired with the blood cell counter 210. Controller / processor 290, along with memory 295 and I / O 297, may be configured to perform various functions associated with the preparation and analysis of flow cytometric experiments.
[0131] Different fluorescent molecules in the fluorescent dye panel for flow cytometer experiment will emit light in its own characteristic wavelength band. Specific fluorescent markers and their related fluorescence emission bands for experiment can be selected to be generally consistent with the filter window of the detector. I / O 297 can be configured to receive data about flow cytometer experiment, and the flow cytometer experiment has a group of fluorescent markers and multiple cell colonies with multiple markers, and each cell colony has a subset of multiple markers. I / O 297 can also be configured to receive biological data, marker density data, emission spectrum data, data and hemocytometer configuration data that one or more markers are assigned to one or more cell colonies. Flow cytometer experiment data, such as marker spectral characteristics and flow cytometer configuration data can also be stored in memory 295. Controller / processor 290 can be configured to evaluate one or more assignments of markers to markers.
[0132] In some embodiments, the subject system is a particle sorting system configured to sort particles using a closed particle sorting module, such as those described in U.S. Patent Publication No. 2017 / 0299493, filed on March 28, 2017 (the disclosure of which is incorporated herein by reference). In certain embodiments, particles (e.g., cells) of a sample are sorted using a sorting decision module having multiple sorting decision units, such as those described in U.S. Patent Publication No. 2020 / 0256781, filed on December 23, 2019 (the disclosure of which is incorporated herein by reference). In some embodiments, a system for sorting components of a sample includes a particle sorting module having a deflection plate, such as described in U.S. Patent Publication No. 2017 / 0299493, filed on March 28, 2017 (the disclosure of which is incorporated herein by reference).
[0133] In certain embodiments, the system is a fluorescence imaging of a particle sorter using radio frequency tag emission enabled images, e.g. Figure 3As shown. The particle sorter 300 includes a light irradiation component 300a, which includes a light source 301 (e.g., a 488nm laser), which generates an output beam 301a, and the output beam is split into beams 302a and 302b by a beam splitter 302. The light beam 302a is propagated through an acousto-optic device (e.g., an acousto-optic deflector, AOD) 303 to generate an output beam 303a of a beam having one or more angles of deflection. In some instances, the output beam 303a generated from the acousto-optic device 303 includes a local oscillator beam and a plurality of radio frequency comb beams. The light beam 302b is propagated through an acousto-optic device (e.g., an acousto-optic deflector, AOD) 304 to generate an output beam 304a of a beam having one or more angles of deflection. In some instances, the output beam 304a generated from the acousto-optic device 304 includes a local oscillator beam and a plurality of radio frequency comb beams. Output beams 303a and 304a generated from the acousto-optic devices 303 and 304, respectively, are combined with a beam splitter 305 to generate an output beam 305a, which is transmitted through an optical component 306 (e.g., an objective lens) to illuminate the particles in the flow cell 307. In some embodiments, the acousto-optic device 303 (AOD) divides a single laser beam into an array of small beams, each of which has a different optical frequency and angle. The second AOD 304 tunes the optical frequency of the reference beam, and then the reference beam overlaps the array of small beams at the beam combiner 305. In some embodiments, the light irradiation system with a light source and an acousto-optic device can also include those described in Schraivogel et al. ("High-speed fluorescence image-enabled cell sorting" Science (2022), 375 (6578): 315-320) and U.S. Patent Publication No. 2021 / 0404943, the disclosures of which are incorporated herein by reference.
[0134] Output beam 305a illuminates sample particle 308 propagating through flow cell 307 (e.g., with sheath fluid 309) at illumination region 310. As shown in illumination region 310, multiple beams (e.g., angularly deflected RF-shifted beams depicted as dots on illumination region 310) overlap with a reference local oscillator beam (depicted as hatched lines on illumination region 310). Due to their different optical frequencies, the overlapping beams exhibit beat frequency behavior, which causes each beamlet to carry a different frequency f 1-n Sinusoidal modulation.
[0135] Light from the irradiated sample is transmitted to a light detection system 300b including multiple photodetectors. The light detection system 300b includes a forward scattered light photodetector 311 for generating a forward scattering image 311a and a side scattered light photodetector 312 for generating a side scattering image 312a. The light detection system 300b also includes a bright field photodetector 313 for generating a light loss image 313a. In some embodiments, the forward scattering detector 311 and the side scattering detector 312 are photodiodes (e.g., avalanche photodiodes, APDs). In some instances, the bright field photodetector 313 is a photomultiplier tube (PMT). Fluorescence from the irradiated sample is also detected with a fluorescence photodetector 314-317. In some instances, the photodetector 314-317 is a photomultiplier tube. The light from the irradiated sample is guided to the side scattering detection channel 312 and the fluorescence detection channel 314-317 by a beam splitter 320. Light detection system 300b includes bandpass optical components 321, 322, 323 and 324 (e.g., dichroic mirrors) for transmitting light of predetermined wavelengths to photodetectors 314-317. In some instances, optical component 321 is a 534nm / 40nm bandpass. In some instances, optical component 322 is a 586nm / 42nm bandpass. In some instances, optical component 323 is a 700nm / 54nm bandpass. In some instances, optical component 324 is a 783nm / 56nm bandpass. The first number represents the center of the spectral band. The second number provides the range of the spectral band. Therefore, a 510 / 20 filter extends 10nm on each side of the center of the spectral band, or extends from 500nm to 520nm.
[0136] Data signals generated in response to light detected in scattered light detection channels 311 and 312, bright field light detection channel 313, and fluorescence detection channels 314-317 are processed by processors 350 and 351 through real-time digital processing. Based on the data signals generated in processors 350 and 351, images 311a-317a can be generated in each light detection channel. Image-enabled sorting is performed in response to a sorting signal generated in a sorting trigger 352. The sorting component 300c includes a deflection plate 331 for deflecting particles into a sample container 332 or a waste stream 333. In some instances, the sorting component 300c is configured to sort particles with a closed particle sorting module, such as those described in U.S. Patent Publication No. 2017 / 0299493 filed on March 28, 2017, the disclosure of which is incorporated herein by reference. In some embodiments, the sorting component 300c includes a sorting decision module having multiple sorting decision units, such as those described in U.S. Patent Publication No. 2020 / 0256781, the disclosure of which is incorporated herein by reference.
[0137] In some embodiments, the system is a particle analyzer, wherein the particle analysis system 401 ( Figure 4 ) can be used to analyze and characterize particles, with or without physically sorting the particles into collection vessels. Figure 4 A functional block diagram of a particle analysis system for computation-based sample analysis and particle characterization is shown. In some embodiments, the particle analysis system 401 is a flow system. The particle analysis system 401 includes a fluidics system 402. The fluidics system 402 can include or be coupled to a sample tube 405 and a moving fluid column within the sample tube, wherein particles 403 (e.g., cells) of the sample move along a common sample path 409.
[0138] Particle analysis system 401 includes a detection system 404 configured to collect signals from each particle as each particle passes through one or more detection stations along a common sample path. Detection station 408 generally refers to monitoring region 407 of the common sample path. In some embodiments, detection can include detecting light or one or more other properties of particle 403 as particle 403 passes through monitoring region 407. Figure 4 , one detection station 408 is shown having one monitoring area 407. Some embodiments of particle analysis system 401 may include multiple detection stations. In addition, some detection stations may monitor more than one area.
[0139] Each signal is assigned a signal value to form a data point for each particle. As described above, this data can be referred to as event data. The data point can be a multi-dimensional data point, including the value of the corresponding property measured for the particle. The detection system 404 is configured to collect a series of such data points in a first time interval.
[0140] The particle analysis system 401 may also include a control system 406. The control system 406 may include one or more processors, amplitude control circuits, and / or frequency control circuits. The control system shown may be operatively associated with the fluidics system 402. The control system may be configured to generate a calculated signal frequency for at least a portion of the first time interval based on a Poisson distribution and the number of data points collected by the detection system 404 during the first time interval. The control system 406 may further be configured to generate an experimental signal frequency based on the number of data points in the portion of the first time interval. The control system 406 may also compare the experimental signal frequency with the calculated signal frequency or a predetermined signal frequency.
[0141] Figure 5A functional block diagram of one example of a particle analyzer control system, such as analysis controller (ie, processor) 500, for analyzing and displaying biological events is shown. Analysis controller 500 may be configured to implement various processes for controlling the graphical display of biological events.
[0142] The particle analyzer or sorting system 502 can be configured to acquire biological event data. For example, a flow cytometer can generate flow cytometry event data. The particle analyzer 502 can be configured to provide biological event data to the analysis controller 500. A data communication channel can be included between the particle analyzer or sorting system 502 and the analysis controller 500. The biological event data can be provided to the analysis controller 500 via the data communication channel. The analysis controller 500 can be a processor configured to implement the method of the present invention, for example, by applying a regression model to determine the relationship between the initial set of analyte features and the clustering criteria, generating a sparse set from at most a portion of the initial set of analyte features based on the relationship, generating a classification model based on the sparse set, and applying the classification model to classify the analyte data into clusters.
[0143] The analysis controller 500 can be configured to receive biological event data from a particle analyzer or sorting system 502. The biological event data received from the particle analyzer or sorting system 502 can include flow cytometry event data. The analysis controller 500 can be configured to provide a graphical display of a first plot including the biological event data to a display device 506. For example, the analysis controller 500 can also be configured to present an area of interest as a gate around a population of biological event data displayed by the display device 506, overlaid on the first plot. In some embodiments, the gate can be a logical combination of one or more graphical areas of interest plotted on a single parameter histogram or a bivariate plot. In some embodiments, the display can be used to display particle parameters or saturated detector data.
[0144] Analysis controller 500 can be further configured to display biological event data on display device 506 inside the door, different from other events in the biological event data outside the door. For example, analysis controller 500 can be configured to display the biological event data contained inside the door in a different color than the biological event data outside the door. Display device 506 can be implemented as a monitor, tablet computer, smart phone, or other electronic device configured to present a graphical interface.
[0145] The analysis controller 500 can be configured to receive a door selection signal identifying a door from a first input device. For example, the first input device can be implemented as a mouse 510. The mouse 510 can initiate a door selection signal to the analysis controller 500, identifying a door to be displayed on the display device 506 or operated via the display device 506 (for example, by clicking on the desired door or in the desired door when the cursor is located on or in the desired door). In some embodiments, the first device can be implemented as a keyboard 508 or other component for providing input signals to the analysis controller 500, such as a touch screen, a stylus, an optical detector, or a voice recognition system. Some input devices may include multiple input functions. In such embodiments, the input functions can each be considered an input device. For example, as Figure 5 As shown, the mouse 510 may include a right mouse button and a left mouse button, each of which may generate a trigger event.
[0146] A triggering event may cause analysis controller 500 to change the manner in which data is displayed, which portions of the data are actually displayed on display device 506, and / or provide input for further processing, such as selecting a population of interest for particle sorting.
[0147] In some embodiments, the analysis controller 500 can be configured to detect when a gate selection is initiated by the mouse 510. The analysis controller 500 can be further configured to automatically modify the plot visualization to facilitate the gating process. The modification can be based on a particular distribution of the bio-event data received by the analysis controller 500.
[0148] Analysis controller 500 may be connected to storage device 504. Storage device 504 may be configured to receive and store biological event data from analysis controller 500. Storage device 504 may also be configured to receive and store flow cytometry event data from analysis controller 500. Storage device 504 may further be configured to allow retrieval of biological event data, such as flow cytometry event data, by analysis controller 500.
[0149] The display device 506 can be configured to receive display data from the analysis controller 500. The display data can include plots of the biological event data and gates outlining portions of the plot. The display device 506 can be further configured to change the information presented based on input received from the analysis controller 500 and in conjunction with input from the particle analyzer 502, the storage device 504, the keyboard 508, and / or the mouse 510.
[0150] In some embodiments, the analysis controller 500 can generate a user interface to receive exemplary events for sorting. For example, the user interface can include a control for receiving exemplary events or exemplary images. The exemplary events or images or exemplary gates can be provided before collecting event data for the sample, or based on an initial set of events for a portion of the sample.
[0151] Fig. 6A is a schematic diagram of a particle sorting system 600 (e.g., a particle analyzer or sorting system 502) according to one embodiment presented herein. In some embodiments, the particle sorting system 600 is a cell sorting system. Fig. 6A As shown, a droplet formation transducer 602 (e.g., a piezoelectric oscillator) is coupled to a fluid conduit 601, which can be coupled to a nozzle 603, can include a nozzle 603, or can be a nozzle 603. Within the fluid conduit 601, a sheath fluid 604 hydrodynamically focuses a sample fluid 606 containing particles 609 into a moving fluid column 608 (e.g., a stream). Within the moving fluid column 608, the particles 609 (e.g., cells) are aligned to span a monitoring area 611 (e.g., where the laser-stream intersects) illuminated by an illumination source 612 (e.g., a laser). The vibration of the droplet formation transducer 602 causes the moving fluid column 608 to break into a plurality of droplets 610, some of which contain particles 609.
[0152] In operation, a detection station 614 (e.g., an event detector) identifies when a particle of interest (or a cell of interest) crosses the monitoring region 611. The detection station 614 feeds into a timing circuit 628, which in turn feeds into a flash charging circuit 630. At a droplet break point informed by a timed droplet delay (Δt), a flash charge can be applied to the moving fluid column 608 so that the droplets of interest carry an electric charge. The droplets of interest may include one or more particles or cells to be sorted. The charged droplets may then be sorted by activating a deflection plate (not shown) to deflect the charged droplets into a vessel such as a collection tube or a multi-well or micro-well sample plate, where the wells or micro-wells may be associated with droplets of particular interest. As Fig. 6A As shown, the droplets may be collected in a receptacle 638 .
[0153] A detection system 616 (e.g., a droplet boundary detector) is used to automatically determine the phase of the droplet drive signal when a particle of interest passes through the monitoring area 611. An exemplary droplet boundary detector is described in U.S. Patent No. 7,679,039 (which is incorporated herein by reference in its entirety). The detection system 616 allows the instrument to accurately calculate the position of each detected particle in the droplet. The detection system 616 can be fed into an amplitude signal 620 and / or a phase 618 signal, which in turn is fed into (via amplifier 622) an amplitude control circuit 626 and / or a frequency control circuit 624. The amplitude control circuit 626 and / or the frequency control circuit 624 in turn controls the droplet formation transducer 602. The amplitude control circuit 626 and / or the frequency control circuit 624 can be included in the control system.
[0154] In some embodiments, the sorting electronics (e.g., detection system 616, detection station 614, and processor 640) can be coupled to a memory configured to store detected events and sorting decisions based on the detected events. The sorting decision can be included in the event data of the particle. In some embodiments, the detection system 616 and the detection station 614 can be implemented as a single detection unit or communicatively coupled so that event measurements can be collected by one of the detection system 616 or the detection station 614 and provided to a non-collecting element.
[0155] Figure 6B is a schematic diagram of a particle sorting system according to one embodiment presented herein. Figure 6B The particle sorting system 600 shown includes deflection plates 652 and 654. The charge can be applied via the stream charge wires in the barbs. This generates a droplet stream 610 containing particles 610 for analysis. The particles can be illuminated with one or more light sources (e.g., lasers) to generate light scattering and fluorescence information. For example, by sorting electronics or other detection systems (in Figure 6B Deflector plates 652 and 654 can be independently controlled to attract or repel charged droplets, thereby directing the droplets toward a destination collection container (e.g., one of 672, 674, 676, or 678). Figure 6B As shown, deflector plates 652 and 654 can be controlled to direct particles along a first path 662 toward a container 674 or along a second path 668 toward a container 678. If the particle is not of interest (e.g., does not show scattering or illumination information within a specified sorting range), the deflector plates can allow the particle to continue along flow path 664. Such uncharged droplets can enter a waste container, for example, via an aspirator 670.
[0156] Sorting electronics may be included to initiate the collection of measurements, receive the fluorescence signals of the particles, and determine how to adjust the deflection plates to cause sorting of the particles. Figure 6B An exemplary implementation of the embodiment shown includes a BD FACSAria CT Scanner commercially available from Becton, Dickinson and Company (Franklin Lakes, NJ). TM Serial flow cytometer.
[0157] Figure 7 Depicted is the overall architecture of an exemplary computing device 700 in accordance with certain embodiments. Figure 7 The overall architecture of the computing device 700 depicted in the figure includes an arrangement of computer hardware and software components. However, it is not necessary to show all of these generally conventional elements in order to provide an achievable disclosure. As shown, the computing device 700 includes a processing unit 710, a network interface 720, a computer-readable medium drive 730, an input / output device interface 740, a display 750, and an input device 760, all of which can communicate with each other via a communication bus. The network interface 720 can provide a connection to one or more networks or computing systems. The processing unit 710 can therefore receive information and instructions from other computing systems or services via the network. The processing unit 710 can also be transmitted to and from the memory 770, and further provide output information to the optional display 750 via the input / output device interface 740. For example, analysis software (e.g., data analysis software or program such as a computer program) stored as executable instructions in a non-temporary memory of the analysis system ) can display flow cytometry event data to a user. The input / output device interface 740 can also accept input from an optional input device 760, such as a keyboard, mouse, digital pen, microphone, touch screen, gesture recognition system, voice recognition system, game controller, accelerometer, gyroscope or other input device.
[0158] The memory 770 may contain computer program instructions (grouped into modules or components in some embodiments) that the processing unit 710 executes to implement one or more embodiments. The memory 770 typically includes RAM, ROM, and / or other persistent computer-readable media, auxiliary computer-readable media, or non-transitory computer-readable media. The memory 770 may store an operating system 772 that provides computer program instructions for use by the processing unit 710 in the general management and operation of the computing device 700. Data may be stored in the data storage device 790. The memory 770 may further include computer program instructions and other information for implementing various aspects of the present disclosure.
[0159] Kits
[0160] Aspects of the present disclosure further include kits, wherein the kit includes storage media, such as magneto-optical disks, CD-ROMs, CD-Rs, magnetic tapes, non-volatile memory cards, ROMs, DVD-ROMs, Blu-ray discs, solid-state hard disks, and network attached storage (NAS). Any of these program storage media or other media currently used or that may be developed later may be included in the subject kit. In an embodiment, the program storage medium includes instructions for classifying flow cytometer data. In an embodiment, the instructions or a portion thereof contained on the computer-readable medium provided in the subject kit may be implemented as a software component of the software for analyzing data. In these embodiments, a computer control system according to the present disclosure may be used as an existing software package (e.g., ) software “plug-ins”.
[0161] In addition to the above-mentioned components, the theme suite may further include (in some embodiments) instructions. These instructions may be present in the theme suite in various forms, one or more of which may be present in the suite. A form in which these instructions may exist is to be present as printed information on a suitable medium or substrate (e.g., one or more sheets of paper with information printed thereon), in the packaging of the suite, in a packaging insert, etc. Another form of these instructions is a computer-readable medium having information recorded thereon, such as a disk, a compact disc (CD), a portable flash drive, etc. Another form of these instructions that may exist is a website address, which may be used to access the information of the site removed via the Internet.
[0162] utility
[0163] The subject particle analyzers, methods, and computer systems may find use in a variety of applications where it is desirable to analyze and optionally sort the particle components of a sample (such as a biological sample) in a fluid medium, and then store the sorted products, e.g., for later use, such as therapeutic uses. The present disclosure finds use particularly where it is desirable to classify flow cytometer data. For example, the subject particle analyzers, methods, and computer systems may be employed to facilitate determining appropriate gates for particular populations or subpopulations of flow cytometer data, particularly in data sets where such appropriate gates are not readily apparent. Embodiments of the present disclosure also find use where it is desirable to provide a flow cytometer having improved cell sorting accuracy, enhanced particle collection, particle charging efficiency, more precise particle charging, and enhanced particle deflection during cell sorting.
[0164] Embodiments of the present disclosure find use in applications for research, laboratory testing, or for cells that may need to be prepared from biological samples for therapy. In some embodiments, subject methods and apparatus can help obtain and / or analyze individual cells prepared from target fluids or tissue biological samples. For example, subject methods and systems help obtain cells to be used as research or diagnostic samples for diseases such as cancer from fluids or tissue samples. Likewise, subject methods and systems can help obtain cells to be used for therapy from fluids or tissue samples.
[0165] The following are presented by way of example and not by way of limitation:
[0166] Experimental
[0167] Experiment 1
[0168] The inclusion of cellular doublets in targeted single cell sorting has significant consequences, as non-target cells can contaminate the sorted product and may lead to misleading or undesirable results in downstream applications. Doublets consisting of cells and unlysed erythrocytes, large exosomes, apoptotic bodies, or platelets can also affect the outcome of the sort. The inclusion and or exclusion of these events in the sort and the impact they may have on the quality of the sorted product are explored.
[0169] In summary, blood mononuclear cells (PBMCs) were prepared from 5 healthy donors by ficol separation. Sample preparations were counterstained with DRAQ5, a membrane-permeable DNA intercalating dye that is compatible with the BD CellView TM Image-Technique Compatible. Singlet, doublet, and cluster frequencies were tracked via DNA content as traditional scatter-based doublet discrimination strategies were compared to image-based methods. Each gate in the workflow was compared using DNA content as the ground truth for singlet events versus non-singlet events. Traditional scatter-based methods (e.g., width versus height and area versus height) were performed along with image-based methods using features of eccentricity and radial moment. Image-based methods were evaluated alone and in conjunction with scatter-based methods. Singlet retention was also evaluated as significant loss of singlets would be an undesirable consequence of any successful doublet exclusion strategy.
[0170] Sample preparation and data acquisition
[0171] Whole blood was collected in standard EDTA sample collection tubes. Peripheral blood mononuclear cells (PBMCs) were prepared using a standard ficol density gradient centrifugation protocol. Blood from 5 healthy donors was processed in parallel. PBMCs were washed and stained with Draq5 (BD Biosciences, catalog number 564902). TMBD FACSDiscover Imaging Technology Prototype TM Cells were collected on S8. TM Data were analyzed using ANALYZER® software (BD Biosciences).
[0172] Manual gating technology
[0173] Scatter-based dual state discrimination gating (SSC and FSC) was done without using imaging in any way as it attempted to capture the practices adopted by users on non-imaging enabled hemocytometers. The use of imaging was not limited to digital image derived features, but also employed pop-up mouse-over imaging to guide gate placement.
[0174] Machine Learning (ML) Algorithm Technology
[0175] A training dataset of 25K events was used to find the regression relationship between the predictor and the target (DRAQ5 DNA stain indicator). A list of the top ten features was generated and then iteratively fine-tuned to obtain a sparse set of 3 features ( Fig. 8A The underlying distribution is assumed to be a multimodal Gaussian mixture, and unsupervised clustering is performed on 375K events (10 datasets) ( Figure 8B ).
[0176] result
[0177] The imaging features used in the manual gating method are eccentricity and radial moment. Eccentricity is the ratio of the shortest axis moment to the longest axis moment within an image in a given scatter or fluorescence channel, while radial moment is the average distance from the centroid (relative center) of all signal-positive pixels within an image in a given scatter or fluorescence channel. Fig. 9 In Figure 2, the distribution of lymphocytes, monocytes, and high scattering events is shown in the scatter plot and the imaging feature plot. Next, the non-singlet exclusion methods based on imaging features and scattering are compared. Fig. 10A As shown, using DRAQ5 (DNA staining) it is possible to count the absolute number of singlets and non-singlet states within each gate. The number of basic real singlets and non-singlet states (based on DNA content) inside and outside each gate is shown as a pie chart. Fig. 10B As shown, using the non-singlet exclusion method using only imaging, 83% of the non-singlet states were excluded and 95% of the total singlet states were retained. FIG. 11A to FIG. 11B The results of using a height-relative-width non-singlet exclusion method in addition to imaging are shown in . This type of workflow combines scattering- and imaging-based methods for doublet discrimination. Fig.11A In the rightmost plot of , a more aggressive gate configured to exclude more non-singlet states is also shown. The metrics from this gate are shown in Fig. 11B , while the results from the other gate are shown in the bottom graph of Fig. 11B In the top picture. FIG. 12A to FIG. 12B Results using non-singlet exclusion using height relative to area plus imaging are shown. This workflow also combines scattering- and imaging-based methods for doublet discrimination. Fig. 12B As shown, 91% of the non-singlet states were excluded, while 92% of the total singlet states were retained. Fig.13A A bar graph of the percentage of total non-singlet states excluded by each method is shown in (n=5 donors). Fig. 13B A bar graph of the percentage of singlet states retained by each is shown in . The data for each donor were normalized to the absolute number of non-singlet / singlet states as measured by DNA content.
[0178] The clustering results of the machine learning based algorithmic approach are plotted. Fig.14A Clustering results of GT singlets (magenta), GT non-singlet states (blue), algorithm-identified non-singlet states (which are true singlets) (orange), and algorithm-identified singlet states (which are true non-singlet states) (light blue) are shown. Fig. 14B All algorithm-identified singlet states (purple) and algorithm-identified non-singlet states (light blue) are shown. Fig.15 The box and whisker plots depicted in show that the median true singlet identification rate is about 97% (blue), and the true doublet exclusion rate is about 92% (orange).The standard deviation of the singlet distribution is 0.52, and the standard deviation of the doublet distribution is 1.72.
[0179] in conclusion
[0180] Doublet discrimination based on scattering excludes approximately 60% of doublets (H relative to W and H relative to A are roughly equal) and retains approximately 95% of singlets. Doublet discrimination based only on imaging features excludes 80% of doublets and retains 95% of singlets. Combining imaging and scattering parameters, 90% of doublets are excluded and 90% of singlets are retained. Aggressive imaging gates are able to exclude 97% of doublets, but only retain 78% of true singlets. ML-based algorithms can include 97% of true singlets and exclude 92% of true non-singlet states. The combination of imaging parameters and non-imaging parameters is powerful for the discrimination of singlets relative to non-singlet states. The potential distribution of events strictly follows the multimodal Gaussian assumption. For this application, Gaussian clustering outperforms K-means, spectral, DBSCAN and BIRCH clustering methods.
[0181] Experiment 2
[0182] An initial feature list was generated using the DRAQ5 DNA stain indicator R3(700)-A channel as the target and all other non-detector channels as predictors. The regression relationship between the predictors and the target produced a list of top 10 features. The list was iteratively adjusted to obtain an empirical list consisting of 3 channels, namely: "Eccentricity (Light Loss (Imaging))", "Light Loss (Purple)-A" and "Size (Light Loss (Imaging))". The final feature list was then used to cluster the available data set consisting of two groups (25K events and 50K events), each containing data from 5 cell donors. Gaussian mixture modeling was applied to the above clustered data set. Gaussian mixture modeling assumes that the data distribution is a Gaussian mixture. For the purposes of this study, the assumption was limited to 2 Gaussian models, one for each singlet and non-singlet population. Several clustering techniques were applied, including DBSCAN, BIRCH, K-means and spectroscopy, but the Gaussian mixture model best explained the data and was selected due to its high specificity and sensitivity. The clustered data were compared to the ground truth DRAQ5 DNA stain indicator R3(700)-A channel distribution. The performance metrics measured were a) singlet inclusion rate and b) non-singlet exclusion rate and are shown in Tables 1 and 2 below for data from 25k events and 50k events, respectively.
[0183] Table 1: Data of 25K events (5 donors)
[0184]
[0185] Table 2: Data of 50K events (5 donors)
[0186]
[0187]
[0188] Notwithstanding the appended claims, the present disclosure is defined by the following terms:
[0189] 1. A computer-implemented method for classifying analyte data into clusters, the method comprising, via a processor:
[0190] Regression models were applied to determine the relationship between the initial set of analyte features and the clustering criteria;
[0191] generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship;
[0192] generating a classification model based on the sparse set; and
[0193] The classification model is applied to classify the analyte data into the clusters.
[0194] 2. A computer-implemented method according to clause 1, wherein the analyte data is flow cytometer data.
[0195] 3. A computer-implemented method according to clause 2, wherein the clustering criterion is the association of the analyte data with a singlet state.
[0196] 4. The computer-implemented method of clause 3, wherein the clusters include singlet clusters and non-singlet clusters.
[0197] 5. The computer-implemented method of clause 4, wherein the non-singlet clusters comprise doublets or aggregates.
[0198] 6. A computer-implemented method according to any one of clauses 2 to 5, wherein the analyte characteristics include size characteristics, imaging characteristics, scattering characteristics, or any combination thereof.
[0199] 7. A computer-implemented method according to clause 6, wherein the analyte characteristic comprises an imaging characteristic.
[0200] 8. A computer-implemented method according to any of the preceding clauses, wherein the classification model comprises a hybrid model.
[0201] 9. The computer-implemented method of clause 8, wherein the mixture model comprises a Gaussian mixture model.
[0202] 10. A computer-implemented method according to any of clauses 1 to 7, wherein the classification model comprises a density-based spatial clustering algorithm.
[0203] 11. The computer-implemented method of clause 10, wherein the density-based spatial clustering algorithm comprises a Density-Based Spatial Clustering of Applications with Noise (DBSCAN) algorithm.
[0204] 12. A computer-implemented method according to any one of clauses 1 to 7, wherein the classification model comprises a Balanced Iterative Reduction and Clustering using Hierarchy (BIRCH) algorithm.
[0205] 13. A computer-implemented method according to any one of clauses 1 to 7, wherein the classification model comprises a K-means clustering algorithm.
[0206] 14. A computer-implemented method according to any one of clauses 1 to 7, wherein the classification model comprises a spectral clustering algorithm.
[0207] 15. A computer-implemented method according to any of the preceding clauses, wherein the initial set of analyte features comprises 5 to 20 analyte features.
[0208] 16. The computer-implemented method of clause 15, wherein the initial set of analyte features comprises 7 to 15 analyte features.
[0209] 17. The computer-implemented method of clause 16, wherein the initial set of analyte features comprises 9 to 11 analyte features.
[0210] 18. A computer-implemented method according to any of the preceding clauses, wherein the initial set of analyte features includes 10% or more of the possible analyte features.
[0211] 19. The computer-implemented method of clause 18, wherein the initial set of analyte features includes 15% or more of the possible analyte features.
[0212] 20. The computer-implemented method of clause 19, wherein the initial set of analyte features includes 20% or more of the possible analyte features.
[0213] 21. A computer-implemented method according to any of the preceding clauses, wherein the sparse set of analyte features comprises 2 to 10 analyte features.
[0214] 22. The computer-implemented method of clause 21, wherein the sparse set of analyte features comprises 2 to 5 analyte features.
[0215] 23. The computer-implemented method of clause 22, wherein the sparse set of analyte features comprises 2 to 4 analyte features.
[0216] 24. A computer-implemented method according to any of the preceding clauses, wherein classifying the analyte data comprises including 90% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0217] 25. The computer-implemented method of clause 24, wherein classifying the analyte data comprises including 95% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0218] 26. The computer-implemented method of clause 25, wherein classifying the analyte data comprises including 97% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0219] 27. A computer-implemented method according to any one of clauses 1 to 23, wherein classifying the analyte data comprises excluding 85% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0220] 28. The computer-implemented method of clause 27, wherein classifying the analyte data comprises excluding 90% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0221] 29. The computer-implemented method of clause 28, wherein classifying the analyte data comprises excluding 92% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0222] 30. A system comprising a memory operably coupled to a processor, wherein the memory comprises instructions stored thereon that, when executed by the processor, cause the processor to:
[0223] Regression models were applied to determine the relationship between the initial set of analyte features and the clustering criteria;
[0224] generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship;
[0225] generating a classification model based on the sparse set; and
[0226] The classification model is applied to classify the analyte data into the clusters.
[0227] 31. A system according to clause 30, wherein the analyte data is flow cytometry data.
[0228] 32. A system according to clause 31, wherein the clustering criterion is the association of the flow cytometer data with singlets.
[0229] 33. The system of clause 32, wherein the clusters include singlet clusters and non-singlet clusters.
[0230] 34. The system of clause 33, wherein the non-singlet clusters comprise doublets or aggregates.
[0231] 35. A system according to any one of clauses 31 to 34, wherein the analyte characteristic comprises a size characteristic, an imaging characteristic, a scattering characteristic, or any combination thereof.
[0232] 36. A system according to clause 35, wherein the analyte characteristic comprises an imaging characteristic.
[0233] 37. A system according to any of clauses 30 to 36, wherein the classification model comprises a hybrid model.
[0234] 38. A system according to clause 37, wherein the mixture model comprises a Gaussian mixture model.
[0235] 39. A system according to any of clauses 30 to 36, wherein the classification model comprises a density-based spatial clustering algorithm.
[0236] 40. The system of clause 39, wherein the density-based spatial clustering algorithm comprises a Density-Based Spatial Clustering of Applications with Noise (DBSCAN) algorithm.
[0237] 41. A system according to any of clauses 30 to 36, wherein the classification model comprises a Balanced Iterative Reduction and Clustering using Hierarchy (BIRCH) algorithm.
[0238] 42. A system according to any of clauses 30 to 36, wherein the classification model comprises a K-means clustering algorithm.
[0239] 43. A system according to any of clauses 30 to 36, wherein the classification model comprises a spectral clustering algorithm.
[0240] 44. A system according to any one of clauses 30 to 43, wherein the initial set of analyte features comprises 5 to 20 analyte features.
[0241] 45. A system according to clause 44, wherein the initial set of analyte features includes 7 to 15 analyte features.
[0242] 46. A system according to clause 45, wherein the initial set of analyte features includes 9 to 11 analyte features.
[0243] 47. A system according to any one of clauses 30 to 46, wherein the initial set of analyte features comprises 10% or more of the possible analyte features.
[0244] 48. The system of clause 47, wherein the initial set of analyte features includes 15% or more of the possible analyte features.
[0245] 49. The system of clause 48, wherein the initial set of analyte features includes 20% or more of the possible analyte features.
[0246] 50. The system of any one of clauses 30 to 49, wherein the sparse set of analyte features comprises 2 to 10 analyte features.
[0247] 51. The system of clause 50, wherein the sparse set of analyte features comprises 2 to 5 analyte features.
[0248] 52. A system according to clause 51, wherein the sparse set of analyte features includes 2 to 4 analyte features.
[0249] 53. The system of any of clauses 30 to 52, wherein classifying the analyte data comprises including 90% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0250] 54. The system of clause 53, wherein classifying the analyte data comprises including 95% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0251] 55. The system of clause 54, wherein classifying the analyte data comprises including 97% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0252] 56. The system of clauses 30 to 52, wherein classifying the analyte data comprises excluding 85% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0253] 57. The system of clause 56, wherein classifying the analyte data comprises excluding 90% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0254] 58. The system of clause 57, wherein classifying the analyte data comprises excluding 92% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0255] 59. The system of any one of clauses 30 to 58, further comprising a display configured to output the classified analyte data.
[0256] 60. The system of any one of clauses 30 to 59, further comprising a flow cytometer operably connected to the processor.
[0257] 61. A non-transitory computer-readable storage medium comprising instructions stored thereon for classifying analyte data into clusters by a method comprising:
[0258] Regression models were applied to determine the relationship between the initial set of analyte features and the clustering criteria;
[0259] generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship;
[0260] generating a classification model based on the sparse set; and
[0261] The classification model is applied to classify the analyte data into the clusters.
[0262] 62. The non-transitory computer-readable storage medium of clause 61, wherein the analyte data is flow cytometry data.
[0263] 63. The non-transitory computer-readable storage medium of clause 62, wherein the clustering criterion is an association of the analyte data with a singlet state.
[0264] 64. The non-transitory computer-readable storage medium of clause 63, wherein the clusters include singlet clusters and non-singlet clusters.
[0265] 65. The non-transitory computer-readable storage medium of clause 64, wherein the non-singlet clusters comprise doublets or aggregates.
[0266] 66. The non-transitory computer-readable storage medium of any one of clauses 62 to 65, wherein the analyte characteristic comprises a size characteristic, an imaging characteristic, a scattering characteristic, or any combination thereof.
[0267] 67. The non-transitory computer-readable storage medium of clause 66, wherein the analyte characteristic comprises an imaging characteristic.
[0268] 68. The non-transitory computer-readable storage medium of any one of clauses 61 to 67, wherein the classification model comprises a hybrid model.
[0269] 69. The non-transitory computer-readable storage medium of clause 68, wherein the mixture model comprises a Gaussian mixture model.
[0270] 70. The non-transitory computer-readable storage medium of any one of clauses 61 to 67, wherein the classification model comprises a density-based spatial clustering algorithm.
[0271] 71. The non-transitory computer-readable storage medium of clause 70, wherein the density-based spatial clustering algorithm comprises a Density-Based Spatial Clustering of Applications with Noise (DBSCAN) algorithm.
[0272] 72. The non-transitory computer-readable storage medium of any one of clauses 61 to 67, wherein the classification model comprises a Balanced Iterative Reduction and Clustering using Hierarchy (BIRCH) algorithm.
[0273] 73. The non-transitory computer-readable storage medium of any one of clauses 61 to 67, wherein the classification model comprises a K-means clustering algorithm.
[0274] 74. The non-transitory computer-readable storage medium of any one of clauses 61 to 67, wherein the classification model comprises a spectral clustering algorithm.
[0275] 75. The non-transitory computer-readable storage medium of any one of clauses 61 to 74, wherein the initial set of analyte features comprises 5 to 20 analyte features.
[0276] 76. The non-transitory computer-readable storage medium of clause 75, wherein the initial set of analyte features comprises 7 to 15 analyte features.
[0277] 77. The non-transitory computer-readable storage medium of clause 76, wherein the initial set of analyte features comprises 9 to 11 analyte features.
[0278] 78. The non-transitory computer-readable storage medium of any one of clauses 61 to 77, wherein the initial set of analyte signatures comprises 10% or more of the possible analyte signatures.
[0279] 79. The non-transitory computer-readable storage medium of clause 78, wherein the initial set of analyte signatures includes 15% or more of the possible analyte signatures.
[0280] 80. The non-transitory computer-readable storage medium of clause 79, wherein the initial set of analyte signatures includes 20% or more of the possible analyte signatures.
[0281] 81. The non-transitory computer-readable storage medium of any one of clauses 61 to 80, wherein the sparse set of analyte features comprises 2 to 10 analyte features.
[0282] 82. The non-transitory computer-readable storage medium of clause 81, wherein the sparse set of analyte features comprises 2 to 5 analyte features.
[0283] 83. The non-transitory computer-readable storage medium of clause 82, wherein the sparse set of analyte features comprises 2 to 4 analyte features.
[0284] 84. The non-transitory computer-readable storage medium of any one of clauses 61 to 83, wherein classifying the analyte data comprises including 90% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0285] 85. The non-transitory computer-readable storage medium of clause 84, wherein classifying the analyte data comprises including 95% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0286] 86. The non-transitory computer-readable storage medium of clause 85, wherein classifying the analyte data comprises including 97% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0287] 87. The non-transitory computer-readable storage medium of any one of clauses 61 to 83, wherein classifying the analyte data comprises excluding 85% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0288] 88. The non-transitory computer-readable storage medium of clause 87, wherein classifying the analyte data comprises excluding 90% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0289] 89. The non-transitory computer-readable storage medium of clause 88, wherein classifying the analyte data comprises excluding 92% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0290] 90. A computer-implemented method of classifying analyte data into clusters, the method comprising:
[0291] (a) providing analyte data to a system including instructions stored thereon, the instructions, when executed by a processor, causing the processor to:
[0292] Regression models were applied to determine the relationship between the initial set of analyte features and the clustering criteria;
[0293] generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship;
[0294] generating a classification model based on the sparse set; and
[0295] applying the classification model to classify the analyte data into the clusters; and
[0296] (b) receiving the classified analyte data from the processor.
[0297] 91. A computer-implemented method according to clause 90, wherein the analyte data is flow cytometry data.
[0298] 92. A computer-implemented method according to clause 91, wherein the clustering criterion is an association of the analyte data with a singlet state.
[0299] 93. The computer-implemented method of clause 92, wherein the clusters include singlet clusters and non-singlet clusters.
[0300] 94. The computer-implemented method of clause 93, wherein the non-singlet clusters comprise doublets or aggregates.
[0301] 95. A computer-implemented method according to any one of clauses 91 to 94, wherein the analyte characteristics include size characteristics, imaging characteristics, scattering characteristics, or any combination thereof.
[0302] 96. A computer-implemented method according to clause 95, wherein the analyte characteristic comprises an imaging characteristic.
[0303] 97. A computer-implemented method according to any one of clauses 90 to 96, wherein the classification model comprises a hybrid model.
[0304] 98. A computer-implemented method according to any one of clauses 90 to 97, wherein the mixture model comprises a Gaussian mixture model.
[0305] 99. A computer-implemented method according to any one of clauses 90 to 96, wherein the classification model comprises a density-based spatial clustering algorithm.
[0306] 100. The computer-implemented method of clause 99, wherein the density-based spatial clustering algorithm comprises a Density-Based Spatial Clustering of Applications with Noise (DBSCAN) algorithm.
[0307] 101. A computer-implemented method according to any of clauses 90 to 96, wherein the classification model comprises a Balanced Iterative Reduction and Clustering using Hierarchy (BIRCH) algorithm.
[0308] 102. A computer-implemented method according to any one of clauses 90 to 96, wherein the classification model comprises a K-means clustering algorithm.
[0309] 103. A computer-implemented method according to any of clauses 90 to 96, wherein the classification model comprises a spectral clustering algorithm.
[0310] 104. A computer-implemented method according to any one of clauses 90 to 103, wherein the initial set of analyte features comprises 5 to 20 analyte features.
[0311] 105. The computer-implemented method of clause 104, wherein the initial set of analyte features comprises 7 to 15 analyte features.
[0312] 106. The computer-implemented method of clause 105, wherein the initial set of analyte features comprises 9 to 11 analyte features.
[0313] 107. A computer-implemented method according to any one of clauses 90 to 106, wherein the initial set of analyte features comprises 10% or more of the possible analyte features.
[0314] 108. The computer-implemented method of clause 107, wherein the initial set of analyte features includes 15% or more of the possible analyte features.
[0315] 109. The computer-implemented method of clause 108, wherein the initial set of analyte features includes 20% or more of the possible analyte features.
[0316] 110. A computer-implemented method according to any one of clauses 90 to 109, wherein the sparse set of analyte features comprises 2 to 10 analyte features.
[0317] 111. The computer-implemented method of clause 110, wherein the sparse set of analyte features comprises 2 to 5 analyte features.
[0318] 112. A computer-implemented method according to clause 111, wherein the sparse set of analyte features includes 2 to 4 analyte features.
[0319] 113. A computer-implemented method according to any of clauses 90 to 112, wherein classifying the analyte data comprises including 90% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0320] 114. The computer-implemented method of clause 113, wherein classifying the analyte data comprises including 95% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0321] 115. The computer-implemented method of clause 114, wherein classifying the analyte data comprises including 97% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
[0322] 116. A computer-implemented method according to any of clauses 90 to 112, wherein classifying the analyte data comprises excluding 85% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0323] 117. The computer-implemented method of clause 116, wherein classifying the analyte data comprises excluding 90% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0324] 118. The computer-implemented method of clause 117, wherein classifying the analyte data comprises excluding 92% or more of the analyte data not associated with the clustering criteria from the clusters associated with the clustering criteria.
[0325] 119. A computer-implemented method according to any one of clauses 90 to 118, wherein the method comprises receiving the classified analyte data on a display.
[0326] Although the foregoing disclosure has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be apparent to one of ordinary skill in the art in light of the teachings of this disclosure that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
[0327] Therefore, the above only illustrates the principle of the present disclosure.It should be understood that those skilled in the art will be able to design a variety of arrangements, which, although not explicitly described or shown herein, embody the principle of the present disclosure and are included in the spirit and scope of the present disclosure.In addition, all examples and conditional language stated herein are mainly intended to help readers understand the principle of the present disclosure and the concept that the present disclosure contributes to advance the prior art, and should be interpreted as not being limited to such specifically described examples and conditions.In addition, all statements of the principles, aspects and embodiments of the present disclosure and its specific examples are stated herein to cover both its structural equivalents and functional equivalents.In addition, it is intended that such equivalents include both currently known equivalents and future developed equivalents, that is, any element of the development that performs the same function, regardless of the structure.In addition, anything disclosed herein is not intended to be dedicated to the public, regardless of whether such disclosure is explicitly stated in the claims.
[0328] Therefore, the scope of the present disclosure is not intended to be limited to the exemplary embodiments shown and described herein. Instead, the scope and spirit of the present disclosure are embodied by the appended claims. In the claims, 35 U.S.C. § 112(f) or 35 U.S.C. § 112(6) is expressly defined as a limitation to be cited for use in a claim only when the exact phrase "means for..." or the exact phrase "step for..." is cited at the beginning of such limitation in the claim; if such exact phrase is not used in the limitation of the claim, 35 U.S.C. § 112(f) or 35 U.S.C. § 112(6) is not cited.
Claims
1. A computer-implemented method for classifying analyte data into clusters, the method comprising, via a processor: Regression models were applied to determine the relationship between the initial set of analyte features and the clustering criteria; generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship; generating a classification model based on the sparse set; as well as The classification model is applied to classify the analyte data into the clusters.
2. The computer-implemented method of claim 1, wherein the analyte data is flow cytometry data.
3. The computer-implemented method of claim 2, wherein the clustering criterion is an association of the analyte data with a singlet state. The computer-implemented method of claim 3 , wherein the clusters include singlet clusters and non-singlet clusters. The computer-implemented method of claim 4 , wherein the non-singlet clusters include doublets or aggregates.
6. The computer-implemented method of any one of claims 2 to 5, wherein the analyte features comprise size features, imaging features, scattering features, or any combination thereof.
7. The computer-implemented method of claim 6, wherein the analyte feature comprises an imaging feature.
8. A computer-implemented method according to any of the preceding claims, wherein the classification model comprises a mixture model, preferably a Gaussian mixture model, or a Density-Based Spatial Clustering of Applications with Noise (DBSCAN) algorithm, or a Balanced Iterative Reduction and Clustering using Hierarchy (BIRCH) algorithm, or a K-means clustering algorithm, or a spectral clustering algorithm.
9. The computer-implemented method of any one of the preceding claims, wherein the initial set of analyte features comprises 5 to 20 analyte features.
10. The computer-implemented method of any one of the preceding claims, wherein the initial set of analyte features comprises 10% or more of the possible analyte features.
11. The computer-implemented method of any one of the preceding claims, wherein the sparse set of analyte features comprises 2 to 10 analyte features.
12. The computer-implemented method of any of the preceding claims, wherein classifying the analyte data comprises including 90% or more of the analyte data associated with the clustering criteria in the clusters associated with the clustering criteria.
13. A system comprising a memory operably coupled to a processor, wherein the memory comprises instructions stored thereon that, when executed by the processor, cause the processor to: Regression models were applied to determine the relationship between the initial set of analyte features and the clustering criteria; generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship; generating a classification model based on the sparse set; as well as The classification model is applied to classify the analyte data into clusters.
14. A non-transitory computer-readable storage medium comprising instructions stored thereon for classifying analyte data into clusters by a method comprising: Regression models were applied to determine the relationship between the initial set of analyte features and the clustering criteria; generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship; generating a classification model based on the sparse set; as well as The classification model is applied to classify the analyte data into the clusters.
15. A computer-implemented method of classifying analyte data into clusters, the method comprising: (a) providing analyte data to a system including instructions stored thereon, the instructions, when executed by the processor, causing the processor to: Regression models were applied to determine the relationship between the initial set of analyte features and the clustering criteria; generating a sparse set from at most a portion of the initial set of the analyte features based on the relationship; generating a classification model based on the sparse set; as well as applying the classification model to classify the analyte data into the clusters; and (b) receiving the classified analyte data from the processor.
